US20020177889A1 - Ballon catheters having ultraonically driven interface surfaces and methods for their use - Google Patents
Ballon catheters having ultraonically driven interface surfaces and methods for their use Download PDFInfo
- Publication number
- US20020177889A1 US20020177889A1 US10/179,669 US17966902A US2002177889A1 US 20020177889 A1 US20020177889 A1 US 20020177889A1 US 17966902 A US17966902 A US 17966902A US 2002177889 A1 US2002177889 A1 US 2002177889A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- balloon
- interface surface
- angioplasty
- balloons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
Definitions
- the present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for performing angioplasty, stent delivery, and related procedures using balloon catheters having ultrasonically oscillated surfaces which can impart energy to a blood vessel being treated.
- vascular diseases such as acute myocardial infarction (heart attack) and peripheral arterial thrombosis (blood clots in leg arteries)
- acute myocardial infarction heart attack
- peripheral arterial thrombosis blood clots in leg arteries
- the core of the problem is that diseased sites within the blood vessels narrow and eventually become completely blocked as a result of the deposition of fatty materials, cellular debris, calcium, and/or blood clots, thereby blocking the vital flow of blood.
- Current treatments include drugs, interventional devices, and/or bypass surgery.
- High doses of thrombolytics clot-dissolving drugs
- thrombolytics fail to restore blood flow in the affected vessel in about 30% of patients.
- these drugs can also dissolve beneficial clots or injure healthy tissue causing potentially fatal bleeding complications.
- interventional devices including angioplasty, atherectomy, and laser ablation catheters
- the use of such devices to remove obstructing deposits may leave behind a wound that heals by forming a scar.
- the scar itself may eventually become a serious obstruction in the blood vessel (a process known as restenosis).
- diseased blood vessels being treated with interventional devices sometimes develop vasoconstriction (elastic recoil), a process by which spasms or abrupt reclosures of the vessel occur, thereby restricting the flow of blood and necessitating further intervention.
- vasoconstriction elastic recoil
- Ultrasonic energy has been proposed both to mechanically disrupt clot and to enhance the intravascular delivery of drugs to dissolve clot and inhibit restenosis.
- Ultrasonic energy may be delivered intravascularly using specialized catheters having an ultrasonically vibrating surface at or near their distal ends.
- the present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for performing angioplasty, stent delivery, and related procedures using balloon catheters having ultrasonically oscillated surfaces which can impart energy to a blood vessel being treated.
- vascular diseases such as acute myocardial infarction (heart attack) and peripheral arterial thrombosis (blood clots in leg arteries)
- acute myocardial infarction heart attack
- peripheral arterial thrombosis blood clots in leg arteries
- the core of the problem is that diseased sites within the blood vessels narrow and eventually become completely blocked as a result of the deposition of fatty materials, cellular debris, calcium, and/or blood clots, thereby blocking the vital flow of blood.
- Current treatments include drugs, interventional devices, and/or bypass surgery.
- High doses of thrombolytics clot-dissolving drugs
- thrombolytics fail to restore blood flow in the affected vessel in about 30% of patients.
- these drugs can also dissolve beneficial clots or injure healthy tissue causing potentially fatal bleeding complications.
- interventional devices including angioplasty, atherectomy, and laser ablation catheters
- the use of such devices to remove obstructing deposits may leave behind a wound that heals by forming a scar.
- the scar itself may eventually become a serious obstruction in the blood vessel (a process known as restenosis).
- diseased blood vessels being treated with interventional devices sometimes develop vasoconstriction (elastic recoil), a process by which spasms or abrupt reclosures of the vessel occur, thereby restricting the flow of blood and necessitating further intervention.
- vasoconstriction elastic recoil
- Ultrasonic energy has been proposed both to mechanically disrupt clot and to enhance the intravascular delivery of drugs to dissolve clot and inhibit restenosis.
- Ultrasonic energy may be delivered intravascularly using specialized catheters having an ultrasonically vibrating surface at or near their distal ends.
- vascular diseases particularly stenotic diseases which occlude the coronary and other arteries.
- methods and devices for enhancing the performance of angioplasty procedures where the ability to introduce an angioplasty catheter through a wholly or partly obstructed blood vessel lumen can be improved.
- mechanisms as part of an angioplasty catheter which mechanisms can assist in initial balloon deployment and/or decrease the likelihood of subsequent clot formation and restenosis.
- the devices, systems, and methods should further be useful with other procedures which employ balloon catheters, including stent deployment and drug delivery, where drug delivery can be achieved by deploying a pair of spaced-apart balloons for defining a treatment region therebetween.
- a catheter system having a pair of spaced-apart balloons with a coiled piezoelectric strip therebetween is described in U.S. Pat. No. 5,279,546.
- Catheters having elongate ultrasonic transmission elements and inflatable cuffs are described in U.S. Pat. Nos. 5,397,301; 5,304,115; and 4,870,953.
- a tunneling catheter having a radiofrequency, laser, or ultrasonic active distal end disposed within an angioplasty catheter is described in EP 189 329.
- An atherectomy catheter having an ultrasonically enhanced blade disposed adjacent an asymmetrically mounted balloon is described in U.S. Pat. No. 5,085,662.
- Phonophoresis transducers disposed within porous, inflatable balloons are suggested in U.S. Pat. Nos. 5,286,254 and 5,282,785.
- Other catheters having ultrasonic elements with the capability of delivering thrombolytic and other liquid agents are described in U.S. Pat. Nos. 5,362,309; 5,318,014; 5,315,998; 5,197,946; 5,380,273; 5,344,395; 5,342,292; 5,324,255; 5,269,297; 5,267,954; 4,808,153; 4,692,139; and 3,565,062; in WO 90/01300; and in Tachibana (1992) JVIR 3:299-303.
- a rigid ultrasonic probe intended for treating vascular plaque and having fluid delivery means is described in U.S. Pat. No. 3,433,226.
- An ultrasonic transmission wire intended for intravascular treatment is described in U.S. Pat. No. 5,163,421 and Rosenschein et al. (1990) JACC 15:711-717.
- Ultrasonic enhancement of systemic and localized drug delivery is described in U.S. Pat. Nos. 5,267,985; and 4,948,587; in WO 94/05361 and WO 91/19529; in JP 3-63041; and Yumita et al. (1990) Jpn. J. Cancer Res. 81:304-308.
- An electrosurgical angioplasty catheter having ultrasonic enhancement is described in U.S.
- improved devices and systems which combine both an inflatable balloon and an axially oscillated interface surface on a single catheter device.
- the devices and systems are useful for a number of intervascular procedures, including ( 1 ) angioplasty and related procedures, such as stent deployment, where ultrasonic energy delivered by the interface surface can soften the stenotic material in the blood vessel to facilitate deployment and initial treatment and can also reduce residual clot in the treated region in order to lessen the likelihood of restenosis, and (2) drug delivery methods where balloons are used to isolate a treatment region and at least one of the balloons is coupled to the interface surface so that oscillation of the balloon(s) enhances mixing and penetration of a treatment medium localized between the balloons.
- the catheters of the present invention will comprise a catheter body having a proximal end and a distal end.
- An oscillating driver is disposed at or near the distal end of the catheter body, and an interface surface is mechanically coupled to the driver so that the surface can be axially oscillated relative to the catheter body.
- An inflatable balloon is also disposed on the catheter body near the interface surface, where the balloon can be used for angioplasty, stent deployment, or the like, and optionally can be combined with a second balloon to define a drug treatment region therebetween.
- the interface surface comprises a distal tip which extends laterally over the distal end of the catheter body.
- An angioplasty or stent delivery balloon is disposed on the catheter body proximal to the interface surface.
- the interface surface can further include a cylindrical portion which extends over an axial surface of the catheter body. In either case, a distal end of the balloon can be secured directly to the interface surface so that the balloon itself is caused to directly oscillate as the interface surface is oscillated by the driver.
- the catheters having interface surfaces including a laterally disposed distal tip will facilitate penetration of the catheter through a partly or wholly occluded stenotic region within a blood vessel.
- the distal tip will be driven, and the catheter advanced through the stenotic material, with the ultrasonic energy softening the stenotic material to facilitate advance of the catheter.
- the balloon which is proximal to the distal tip, may then be used for either an angioplasty procedure, stent delivery, or both.
- the interface surface on the catheter can thereafter be used to further treat the stenotic region with ultrasonic energy to reduce the amount of clot remaining in order to lessen the likelihood of further clot formation and restenosis.
- the interface surface is disposed at least partly within the inflatable balloon on the catheter body.
- the interface surface and associated oscillatory driver are both located entirely within the inflatable balloon, so that the interface surface can be used to transfer ultrasonic energy directly into the inflation medium used to inflate the balloon.
- the balloon is mounted so that at least one of its forward end and/or distal end is secured to a cylindrical interface surface. In this way, after balloon inflation, the interface surface will directly oscillate one or both ends of the balloon.
- the catheters of this type will be particularly useful for performing enhanced angioplasty procedures, optionally with stent delivery.
- a third exemplary embodiment of the catheter of the present invention comprises a pair of spaced-apart inflatable balloons on the catheter body.
- a cylindrical interface surface is disposed between the balloons, with at least one of the distal end of the proximal-most balloon and the proximal end of the distal-most balloon being secured to the interface member.
- a fluid delivery lumen is provided within the catheter so that a treatment medium can be delivered to the region between the balloons when the balloons are expanded in a blood vessel. Mixing and/or penetration of the treatment medium is enhanced by ultrasonic oscillation of the cylindrical interface surface when the treatment medium is present.
- FIG. 1 illustrates an exemplary catheter incorporating an interface surface having a distal tip and an angioplasty balloon disposed proximally of the interface surface, constructed in accordance with the principles of the present invention.
- FIG. 2 is a detailed view of the distal end of the catheter of FIG. 1, shown in partial section.
- FIG. 3 is a detailed view of the distal end of a first alternative embodiment of the catheter of FIG. 1, wherein the interface surface further extends over a cylindrical portion of the catheter body, shown in partial section.
- FIG. 4 is a detailed view of the distal end of a second alternative embodiment of the catheter of FIG. 1, wherein the angioplasty balloon is attached at its distal end to the interface surface.
- FIG. 5 is a detailed view of the distal end of a third alternative embodiment of the catheter of FIG. 1, wherein the distal end of the angioplasty balloon is attached to the cylindrical portion of the interface surface of the first alternative embodiment of FIG. 2.
- FIGS. 6 - 8 illustrate use of the catheter of FIG. 2 for penetrating a stenotic region within a blood vessel and expanding a vascular stent therein.
- FIG. 9 illustrates the distal end of a fourth alternative embodiment of the catheter of the present invention, wherein a cylindrical interface surface is disposed entirely within an angioplasty balloon.
- FIG. 10 illustrates a fifth alternative embodiment of the catheter of the present invention, wherein the angioplasty balloon is attached at both its proximal and distal ends to a cylindrical interface surface.
- FIG. 11 is a view of the distal end of the catheter of FIG. 9, shown in partial section.
- FIGS. 12 and 13 illustrate use of the catheter of FIG. 9 for expanding a stent within a stenotic region in a blood vessel.
- FIG. 14 illustrates a sixth alternative embodiment of the catheter of the present invention, wherein the catheter includes a pair of axially spaced-apart balloons and wherein the distal end of the proximal-most balloon and the proximal end of the distal-most balloon are each attached to a cylindrical interface surface disposed therebetween.
- the present invention provides apparatus and methods for the treatment of luminal conditions, particularly for the treatment of diseases of the coronary and peripheral vasculature.
- Specific conditions include coronary and peripheral arterial disease and thrombosis.
- the apparatus and methods are useful for primary treatment of such diseases, where the purpose is to ablate, dissolve, or otherwise disrupt the clot, plaque, or other stenotic lesions which are responsible for the disease.
- catheters constructed according to the principles of the present invention can be used to directly engage and transmit vibratory, usually ultrasonic, energy into the stenotic material in order to mechanically disrupt the material to open the associated blood vessel lumen.
- the catheters of the present invention will also include at least one inflatable balloon in order to perform procedures which combine use of the balloon with the ability to deliver ultrasonic or other vibratory energy.
- the balloons will be angioplasty balloons useful for engaging and dilatating stenotic regions within a blood vessel.
- the vibratory energy may be used either to enhance initial penetration of the catheter so that the angioplasty balloon can be positioned within the stenotic region (e.g. by softening or disrupting the stenotic material prior to balloon positioning), to soften the stenotic material while the balloon is being expanded with or without a stent, and/or to treat the stenotic region within the blood vessel after the balloon has been used to perform angioplasty, stent placement, or the like.
- the transfer of ultrasonic energy can reduce the presence of residual clot which can serve as nuclei for subsequent clot formation and restenosis.
- the catheters may also include a pair of spaced-apart balloons, where the balloons define a treatment region therebetween which is useful to enhance the administration of therapeutic agents, where the therapeutic agents are primarily responsible for the disruption of the stenotic material and/or lessening of restenosis subsequent to angioplasty. In such cases, the vibratory energy will be relied on to agitate and promote the penetration of the therapeutic agent into the stenotic material.
- Suitable therapeutic agents include known thrombolytic and fibrinolytic drugs, such as heparin, tissue plasminogen activator (tPA), urokinase, streptokinase, and the like.
- the catheters of the present invention will comprise a catheter body having a proximal end and distal end.
- the catheter body will have dimensions and physical characteristics selected for the particular use.
- the length of the catheter body will typically be from 50 cm to 200 cm, usually being from 75 cm to 150 cm, and the diameter will be from 1 mm to 5 mm, usually being from 2 mm to 4 mm.
- the diameter of the catheter body may vary over its length, and different portions of the length may be formed from different materials.
- the catheter body will comprise a single extrusion having at least one lumen therethrough for providing an inflation medium to the balloon.
- That or another lumen will usually be capable of receiving a guidewire, and may also be capable of delivering therapeutic agents and/or carrying electrical wires for connection from the proximal end of the catheter body to the distal end.
- the catheter body may include separate lumens for balloon inflation, delivering therapeutic agent(s), routing electrical wires for connection to the ultrasonic transducer, or other purposes.
- the catheter body may be reinforced over all or a portion of its length.
- Conventional reinforcement materials include wire braids, wire meshes, wire coils, helical ribbons, and the like.
- the catheter body When employed with a guidewire for placement within the vasculature, the catheter body may have an “over-the-wire” design or a “rapid exchange” design.
- the guidewire lumen will extend substantially through the entire length of the catheter body.
- the guidewire lumen will terminate in a proximal guidewire port located relatively near the distal end of the catheter body, usually within 50 cm, more usually within 30 cm, and often within 25 cm or less.
- a proximal housing will be secured to the proximal end of the catheter body, where the housing includes a guidewire port, a therapeutic agent infusion port, an electrical connector, and the like.
- a longitudinally vibrating assembly is secured at or near the distal end of the catheter body.
- the assembly will include at least one interface surface, usually present on an interface member, which is vibrated at a desired frequency, wherein the interface surface is oriented to transmit vibrations to the fluid environment surrounding the distal end of the catheter.
- the vibrating assembly will usually be attached directly to the distal end of the catheter body but also could be disposed partially or totally within the distal end of the catheter body.
- the vibrating assembly will have a relatively short length, typically being below 2 cm, preferably being below 1 cm, and typically being in the range from about 0.4 cm to 1.5 cm, more usually in the range from about 0.6 cm to 1 cm.
- the assembly will preferably have a low profile (narrow diameter) to facilitate vascular or other intraluminal introductions, typically having a diameter below 6 mm, usually in the range from 1 mm to 5 mm, more usually in the range from 2 mm to 4 mm.
- the interface surface will be forwardly disposed so that the surface may engage intraluminal obstructions as the catheter is advanced through the body lumen, such as a blood vessel.
- the interface member may also or alternatively include an interface surface where at least a portion of the surface is disposed circumferentially about the catheter body.
- the circumferential portion will usually be a cylinder, and the interface member and surface will oscillate axially (i.e., back and forth generally in the direction of the catheter body).
- the energy will radiate away from the cylindrical surface of the interface member in a generally uniform pattern, i.e., isotropically (radially outward).
- Such uniform radiation is particularly advantageous for softening stenotic material and/or for enhancing the penetration of therapeutic agents into a length of an intraluminal wall adjacent a cylindrical interface surface.
- the cylindrical interface surface will typically have a length in the range from 4 mm to 30 mm, preferably from 6 mm to 15 mm.
- the outer diameter of the cylindrical surface will typically be in the range from 2 mm to 5 mm, more usually from 3 mm to 4 mm.
- the interface member may further include a forwardly disposed lateral surface, typically being formed laterally at the distal end of the cylindrical surface.
- the lateral surface may itself be flat, convex (in the form of a forwardly disposed dome at the distal end of the cylindrical surface), concave, or irregular.
- the cylindrical surface and/or the forwardly disposed lateral surface may also have surface irregularities formed therein. For example, a plurality of ridges, protrusions, or the like, may be provided for enhancing the transfer of oscillatory motion into the fluid adjacent the surface.
- An oscillating driver will be provided on the catheter body for oscillating the interface member in a desired manner. Usually, the driver will be separate from the interface member. In some cases, however, it may be possible to provide an oscillatory driver which also defines the interface surface, particularly for radially oscillating drivers as described in copending application Ser. Nos. 08/565,575; 08/566,739; and 08/566,740, the full disclosures of which have previously been incorporated herein by reference.
- the drivers will usually be ultrasonic transducers, including tubular piezoelectric transducers, piezoelectric stack transducers, magnetostrictive drivers, dectostrictive drivers, or the like.
- the drivers may be incorporated in a resonant drive assembly, typically including a spring element attaching the interface member to the catheter body, where the ultrasonic driver is a longitudinally oscillating driver disposed between the catheter body and the interface member.
- Longitudinally oscillating drivers will usually be selected to oscillate with an amplitude in the range from 0.05 ⁇ m to 50 ⁇ m, often from 0.1 ⁇ m to 20 ⁇ m, preferably from 0.5 ⁇ m to 4 ⁇ m.
- the details of such drivers and resonant drive assemblies are set forth in copending application Ser. No. 08/565,575, assigned to the assignee of the present application, the full disclosure of which is incorporated herein by reference.
- the catheters of the present invention will further comprise expansible balloon members disposed proximally and/or distally of the interface surface(s) of the interface member.
- the expansible members typically in the form of inflatable non-compliant and/or elastomeric balloons, may be utilized to perform angioplasty or engage a luminal wall to isolate a luminal region to be treated. Materials and designs for incorporating balloons in intravascular and other catheters are well known in the art.
- a catheter system 10 comprising a catheter 12 constructed in accordance with the principles of the present invention and a power supply 14 is illustrated.
- the catheter 12 includes a catheter body 16 having a distal end 18 and a proximal end 20 , and a proximal housing 22 having a balloon inflation port 24 and a guidewire port 26 .
- the catheter 12 will have at least a second lumen (not illustrated) for accommodating wires transmitting energy from the power supply 14 to an ultrasonic transducer, as described hereinafter.
- Cable 30 extends from the proximal end 20 of the catheter body 16 and includes a connector 32 which mates with connector 32 a on cable 33 from the power supply 14 .
- the power supply 14 will be selected to provide an appropriate current source for driving an ultrasonic transducer, as described in more detail herein below.
- the power supply and transducer will be selected so that the ultrasonic driver typically operates in the range from 1 kHz to 300 kHz, preferably from 20 kHz to 80 kHz.
- the power supply 14 may comprise a conventional signal generator, such as those commercially available from suppliers such as Hewlett-Packard, Palo Alto, Calif., and Tektronics, Portland, Oreg., and a power amplifier, such as those commercially available from suppliers such as ENI, Rochester, N.Y., and Krohn-Hite Corporation, Avon, Mass.
- the catheter 12 includes a vibratory assembly 40 at its distal end 18 .
- the vibratory assembly 40 includes a distal tip 42 connected to a tail mass 44 by a spring member 46 .
- the distal tip 42 , tail mass 44 , and connecting spring 46 may be integrally formed, although such integral construction is not a requirement for the present invention.
- An oscillatory drive assembly 50 is disposed between a proximal surface of the distal tip 42 and a distal surface of the tail mass 44 , and may comprise a cylindrical piezoelectric element, such as those described in copending application Ser. Nos. 08/565,575 and 08/566,739, the full disclosures of which have been incorporated herein by reference.
- the vibratory assembly 40 will be able to longitudinally oscillate the distal tip 42 so that a forwardly disposed lateral surface 52 may be longitudinally oscillated, typically with an amplitude in the range from 0.05 ⁇ m to 20 ⁇ m.
- An angioplasty balloon 60 is disposed on the catheter body 12 proximal to the distal tip 42 , typically being spaced-apart from the tip by a length in the range from 0 mm to 30 mm, typically from 2 mm to 10 mm.
- the balloon 60 may be inflated through an inflation port 62 which is connected to inflation port 24 on the proximal housing 22 .
- FIG. 3 The distal end of an alternative embodiment of the catheter of FIG. 1 is illustrated in FIG. 3.
- a vibratory assembly 70 at the distal end 18 (all common elements of the alternative embodiment will be given the same reference numbers) of the catheter body 12 .
- the vibratory assembly 70 includes a tail mass 44 , and a spring 46 , each of which are identical to the same elements in the catheter of FIGS. 1 and 2.
- the catheter of FIG. 3 includes an interface surface comprising a cylindrical interface surface which extends over a length of the catheter body from 4 mm to 30 mm, preferably from 6 mm to 15 mm.
- the distal end of the interface surface terminates in a lateral surface 52 which may have generally the same geometry as that of the catheter of FIGS. 1 and 2.
- the oscillatory driver 50 will generally be the same as that described previously.
- the primary difference between the vibratory assembly 40 and vibratory assembly 70 is in the nature of the interface surface.
- the interface surface defined by distal tip 42 and FIGS. 1 and 2 provides only a forwardly disposed, lateral interface 52 surface which is useful for engaging stenotic material directly in front of the catheter.
- the vibratory assembly 70 includes an equivalent forwardly disposed interface surface, it further includes a circumferentially disposed cylindrical surface which can impart vibratory energy radially outwardly into fluid surrounding the catheter tip.
- the nature and advantages of such cylindrical and other laterally disposed interface surfaces are described in more detail in copending application Ser. No. 08/566,739, the full disclosure of which has previously been incorporated herein by reference.
- angioplasty balloons may be partly or wholly connected to the interface surfaces which are vibrated by the oscillatory drivers.
- a balloon 80 may be attached at its proximal end 82 to the catheter body 12 and at its distal end 84 to the distal tip 42 .
- the distal end of the balloon 80 may be directly vibrated by the distal tip 42 in order to impart oscillatory energy to the balloon.
- the balloon may thus be directly vibrated and enhance the transfer of oscillatory energy into the fluid medium surrounding the catheter.
- a balloon 90 may have its distal end 94 attached to the cylindrical interface surface 72 of the catheter of FIG. 3, as illustrated in FIG. 5.
- the catheter of FIG. 3 may be used to perform angioplasty and optionally deliver a stent ST.
- the catheter is delivered over a guidewire GW until the distal interface surface 52 of the catheter engages the stenotic material S within a blood vessel BV.
- the oscillatory driver of the catheter is then actuated so that the distal surface 52 is longitudinally oscillated in order to soften the stenotic material S and enhance penetration of the catheter through the stenotic material.
- ultrasonic energy may be radiated forwardly in a pattern indicated by wave front lines 74 , as shown in FIG. 6.
- the balloon 60 may be inflated, optionally expanding the stent ST, as illustrated in FIG. 7.
- the catheter may be moved rearwardly so that the cylindrical surface 72 is aligned with the region that has been treated, as illustrated in FIG. 8.
- the catheter may again be actuated, and the cylindrical surface 72 will transfer ultrasonic wave energy into the medium surrounding the distal end of the catheter, as illustrated by the laterally extending transverse wave lines 73 from the surface.
- the ultrasonic energy will further reduce any residual clot or other stenotic materials which may be present after the dilatation in order to reduce the likelihood of restenosis.
- FIGS. 9 - 11 further alternative embodiments of the catheter of the present invention will be illustrated.
- a cylindrical interface surface 100 is disposed completely within inflatable angioplasty balloon 102 .
- An inflation port 104 is provided on the catheter body 106 , and actuation of the oscillatory driver, as illustrated in FIG. 11, will impart transverse waves into the inflation medium within the balloon 102 .
- a balloon 110 is attached at both its distal and proximal ends to a cylindrical interface surface 112 . In this way, when the interface surface 112 is actuated, both ends of the balloon 112 will be longitudinally oscillated together with the surface.
- a first tubular transducer 120 and a second tubular transducer 122 are disposed on the proximal and distal sides of a flange 124 which is located in the middle of a tubular holder 126 .
- the transducers 120 and 122 are tubular piezoelectric transducers, but they could also be piezoelectric stack transducers, magnetostrictive drivers, or the like, as described in more detail in copending application Ser. Nos. 08/565,575; 08/566,739; and 08/566,740, the full disclosures of which have previously been incorporated herein by reference.
- the transducers 120 and 122 will be wired so that they oscillate longitudinally in the same direction, but 180 out of phase. In this way, the total distance between the proximal end of transducer 120 and the distal end of transducer 122 will remain constant, while the ends of each transducer are displaced axially in a synchronous manner.
- An interface member 130 having the cylindrical interface surface 100 is attached to the respective ends of the first transducer 120 and the second transducer 122 . In this way, the transducers will be driven in a longitudinally oscillating manner at a frequency determined by the characteristics of the transducers and the mass of the interface surface.
- the catheter of FIGS. 9 and 11 may be used to dilatate and optionally deliver a stent to a region of vascular stenosis S in a blood vessel BV.
- the balloon 102 carrying the stent ST is positioned within the region of stenosis S, and thereafter the balloon is inflated, as illustrated in FIG. 12.
- the transducers 120 and 122 are activated in order to longitudinally oscillate the cylindrical surface 102 . Such oscillation induces transverse waves within the inflation medium within the balloon 102 as illustrated in FIG. 13. The energy will be further transferred into the blood vessel wall, softening the stenotic material and enhancing expansion of the balloon 102 and stent ST.
- a catheter 150 having a proximal balloon 152 and a distal balloon 154 is illustrated.
- the balloons are axially spaced-apart, and a cylindrical interface surface 156 is disposed therebetween.
- the interface surface 156 may be constructed identically to the transducer assembly of FIG. 11, except that a fluid transfer port 158 will be provided in order to deliver a treatment medium to the volume between the spaced-apart balloons 152 and 154 .
- the spaced-apart balloons 152 and 154 will be inflated within a blood vessel BV to define a treatment region R therebetween. A liquid treatment medium is then introduced into the treatment region R through the delivery port 158 .
- the cylindrical interface surface will be longitudinally oscillated in order to transfer transverse waves into the medium.
- the distal end of the proximal balloon 152 and proximal end of the distal balloon 154 are secured to opposite ends of the cylindrical interface surface 156 .
- the inwardly disposed surfaces of each balloon are oscillated together with the interface surface 156 .
- the balloons themselves can further act to impart vibratory energy into the treatment medium contained within the treatment region R.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mechanical Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A catheter comprises a catheter body having an oscillating driver, an interface surface mechanically coupled to the driver, and an inflatable balloon disposed near the interface surface. The balloon may be an angioplasty balloon, in which case the interface surface will deliver ultrasonic or other vibratory energy into a blood vessel as part of an angioplasty or related procedure. Alternatively, the catheter may comprise a pair of axially spaced-apart isolation balloons, in which case the interface surface can deliver ultrasonic or other vibratory energy into a treatment region defined between said balloons. The energy can thus act to mix or enhance penetration of a treatment held between said balloons in performing a vascular treatment procedure.
Description
- The present application is a continuation of application Ser. No. 09/808,725 (Attorney Docket No. 017148-000720), filed on Mar. 14, 2001, which was a continuation application Ser. No. 09/205,061 (Attorney Docket No. 017148-0007100) filed on Dec. 4, 1998 (now U.S. Pat. No. 6,287,272), which was a continuation-in-part of application Ser. No. 08/708,589, (Attorney Docket No. 017148-000700), filed on Sep. 5, 1996, now U.S. Pat. No. 5,846,218. The full disclosures of each of these applications is incorporated herein by reference.
- 1. Field of the Invention
- The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for performing angioplasty, stent delivery, and related procedures using balloon catheters having ultrasonically oscillated surfaces which can impart energy to a blood vessel being treated.
- Despite the growing sophistication of medical technology, vascular (blood vessel) diseases, such as acute myocardial infarction (heart attack) and peripheral arterial thrombosis (blood clots in leg arteries), remain a frequent, costly, and very serious problem in health care. Current methods of treatment, often expensive, are not always effective. In the U.S. alone, the cost of treatment and support and the loss of productivity due to vascular diseases together exceed $40 billion per year.
- The core of the problem is that diseased sites within the blood vessels narrow and eventually become completely blocked as a result of the deposition of fatty materials, cellular debris, calcium, and/or blood clots, thereby blocking the vital flow of blood. Current treatments include drugs, interventional devices, and/or bypass surgery. High doses of thrombolytics (clot-dissolving drugs) are frequently used in an effort to dissolve the blood clots. Even with such aggressive therapy, thrombolytics fail to restore blood flow in the affected vessel in about 30% of patients. In addition, these drugs can also dissolve beneficial clots or injure healthy tissue causing potentially fatal bleeding complications.
- While a variety of interventional devices are available, including angioplasty, atherectomy, and laser ablation catheters, the use of such devices to remove obstructing deposits may leave behind a wound that heals by forming a scar. The scar itself may eventually become a serious obstruction in the blood vessel (a process known as restenosis). Also, diseased blood vessels being treated with interventional devices sometimes develop vasoconstriction (elastic recoil), a process by which spasms or abrupt reclosures of the vessel occur, thereby restricting the flow of blood and necessitating further intervention. Approximately 40% of treated patients require additional treatment for restenosis resulting from scar formation occurring over a relatively long period, typically 4 to 12 months, while approximately 1-in-20 patients require treatment for vasoconstriction, which typically occurs from 4 to 72 hours after the initial treatment.
- The use of ultrasonic energy has been proposed both to mechanically disrupt clot and to enhance the intravascular delivery of drugs to dissolve clot and inhibit restenosis. Ultrasonic energy may be delivered intravascularly using specialized catheters having an ultrasonically vibrating surface at or near their distal ends.
- It would be desirable to provide improved devices, systems, and methods, for treating vascular diseases, particularly stenotic diseases which occlude the coronary and other arteries. In particular, it would be desirable to provide methods and devices for enhancing the performance of angioplasty procedures, where the ability to introduce an angioplasty catheter through a wholly or partly obstructed blood vessel lumen can be improved. Moreover, it would be desirable to provide mechanisms as part of an angioplasty catheter, which mechanisms can assist in initial balloon deployment and/or decrease the likelihood of subsequent clot formation and restenosis. The devices, systems, and methods, should further be useful with other procedures which employ balloon catheters, including stent deployment and drug delivery, where drug delivery can be achieved by deploying a pair of spaced-apart balloons for defining a treatment region therebetween.
- The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for performing angioplasty, stent delivery, and related procedures using balloon catheters having ultrasonically oscillated surfaces which can impart energy to a blood vessel being treated.
- Despite the growing sophistication of medical technology, vascular (blood vessel) diseases, such as acute myocardial infarction (heart attack) and peripheral arterial thrombosis (blood clots in leg arteries), remain a frequent, costly, and very serious problem in health care. Current methods of treatment, often expensive, are not always effective. In the U.S. alone, the cost of treatment and support and the loss of productivity due to vascular diseases together exceed $40 billion per year.
- The core of the problem is that diseased sites within the blood vessels narrow and eventually become completely blocked as a result of the deposition of fatty materials, cellular debris, calcium, and/or blood clots, thereby blocking the vital flow of blood. Current treatments include drugs, interventional devices, and/or bypass surgery. High doses of thrombolytics (clot-dissolving drugs) are frequently used in an effort to dissolve the blood clots. Even with such aggressive therapy, thrombolytics fail to restore blood flow in the affected vessel in about 30% of patients. In addition, these drugs can also dissolve beneficial clots or injure healthy tissue causing potentially fatal bleeding complications.
- While a variety of interventional devices are available, including angioplasty, atherectomy, and laser ablation catheters, the use of such devices to remove obstructing deposits may leave behind a wound that heals by forming a scar. The scar itself may eventually become a serious obstruction in the blood vessel (a process known as restenosis). Also, diseased blood vessels being treated with interventional devices sometimes develop vasoconstriction (elastic recoil), a process by which spasms or abrupt reclosures of the vessel occur, thereby restricting the flow of blood and necessitating further intervention. Approximately 40% of treated patients require additional treatment for restenosis resulting from scar formation occurring over a relatively long period, typically 4 to 12 months, while approximately 1-in-20 patients require treatment for vasoconstriction, which typically occurs from 4 to 72 hours after the initial treatment.
- The use of ultrasonic energy has been proposed both to mechanically disrupt clot and to enhance the intravascular delivery of drugs to dissolve clot and inhibit restenosis. Ultrasonic energy may be delivered intravascularly using specialized catheters having an ultrasonically vibrating surface at or near their distal ends.
- It would be desirable to provide improved devices, systems, and methods, for treating vascular diseases, particularly stenotic diseases which occlude the coronary and other arteries. In particular, it would be desirable to provide methods and devices for enhancing the performance of angioplasty procedures, where the ability to introduce an angioplasty catheter through a wholly or partly obstructed blood vessel lumen can be improved. Moreover, it would be desirable to provide mechanisms as part of an angioplasty catheter, which mechanisms can assist in initial balloon deployment and/or decrease the likelihood of subsequent clot formation and restenosis. The devices, systems, and methods, should further be useful with other procedures which employ balloon catheters, including stent deployment and drug delivery, where drug delivery can be achieved by deploying a pair of spaced-apart balloons for defining a treatment region therebetween.
- 2. Description of the Background Art
- A catheter system having a pair of spaced-apart balloons with a coiled piezoelectric strip therebetween is described in U.S. Pat. No. 5,279,546. Catheters having elongate ultrasonic transmission elements and inflatable cuffs are described in U.S. Pat. Nos. 5,397,301; 5,304,115; and 4,870,953. A tunneling catheter having a radiofrequency, laser, or ultrasonic active distal end disposed within an angioplasty catheter is described in EP 189 329. An atherectomy catheter having an ultrasonically enhanced blade disposed adjacent an asymmetrically mounted balloon is described in U.S. Pat. No. 5,085,662. Phonophoresis transducers disposed within porous, inflatable balloons are suggested in U.S. Pat. Nos. 5,286,254 and 5,282,785. Other catheters having ultrasonic elements with the capability of delivering thrombolytic and other liquid agents are described in U.S. Pat. Nos. 5,362,309; 5,318,014; 5,315,998; 5,197,946; 5,380,273; 5,344,395; 5,342,292; 5,324,255; 5,269,297; 5,267,954; 4,808,153; 4,692,139; and 3,565,062; in WO 90/01300; and in Tachibana (1992) JVIR 3:299-303. A rigid ultrasonic probe intended for treating vascular plaque and having fluid delivery means is described in U.S. Pat. No. 3,433,226. An ultrasonic transmission wire intended for intravascular treatment is described in U.S. Pat. No. 5,163,421 and Rosenschein et al. (1990) JACC 15:711-717. Ultrasonic enhancement of systemic and localized drug delivery is described in U.S. Pat. Nos. 5,267,985; and 4,948,587; in WO 94/05361 and WO 91/19529; in JP 3-63041; and Yumita et al. (1990) Jpn. J. Cancer Res. 81:304-308. An electrosurgical angioplasty catheter having ultrasonic enhancement is described in U.S. Pat. No. 4,936,281. An infusion and drainage catheter having an ultrasonic cleaning mechanism is described in U.S. Pat. No. 4,698,058. Angioplasty balloon catheters having axial blade atherectomy, ultrasonic imaging, and rotary blade atherectomy devices at their distal ends are described in U.S. Pat. Nos. 5,053,044; 5,117,831; and 5,181,920, respectively.
- This application is related to the following commonly assigned patents and applications: U.S. Pat. Nos. 5,725,494; 5,728,062; 5,735,811; 5,931,805; Ser. Nos. 09/033,834; 09/223,230; 09/635,033; and 09/653,678. The full disclosures of each of these patents and pending applications are incorporated herein by reference.
- According to the present invention, improved devices and systems are provided which combine both an inflatable balloon and an axially oscillated interface surface on a single catheter device. The devices and systems are useful for a number of intervascular procedures, including (1) angioplasty and related procedures, such as stent deployment, where ultrasonic energy delivered by the interface surface can soften the stenotic material in the blood vessel to facilitate deployment and initial treatment and can also reduce residual clot in the treated region in order to lessen the likelihood of restenosis, and (2) drug delivery methods where balloons are used to isolate a treatment region and at least one of the balloons is coupled to the interface surface so that oscillation of the balloon(s) enhances mixing and penetration of a treatment medium localized between the balloons.
- The catheters of the present invention will comprise a catheter body having a proximal end and a distal end. An oscillating driver is disposed at or near the distal end of the catheter body, and an interface surface is mechanically coupled to the driver so that the surface can be axially oscillated relative to the catheter body. An inflatable balloon is also disposed on the catheter body near the interface surface, where the balloon can be used for angioplasty, stent deployment, or the like, and optionally can be combined with a second balloon to define a drug treatment region therebetween.
- In a first specific embodiment, the interface surface comprises a distal tip which extends laterally over the distal end of the catheter body. An angioplasty or stent delivery balloon is disposed on the catheter body proximal to the interface surface. Optionally, the interface surface can further include a cylindrical portion which extends over an axial surface of the catheter body. In either case, a distal end of the balloon can be secured directly to the interface surface so that the balloon itself is caused to directly oscillate as the interface surface is oscillated by the driver.
- In use, the catheters having interface surfaces including a laterally disposed distal tip will facilitate penetration of the catheter through a partly or wholly occluded stenotic region within a blood vessel. The distal tip will be driven, and the catheter advanced through the stenotic material, with the ultrasonic energy softening the stenotic material to facilitate advance of the catheter. The balloon, which is proximal to the distal tip, may then be used for either an angioplasty procedure, stent delivery, or both. In either case, the interface surface on the catheter can thereafter be used to further treat the stenotic region with ultrasonic energy to reduce the amount of clot remaining in order to lessen the likelihood of further clot formation and restenosis.
- In a second specific embodiment, the interface surface is disposed at least partly within the inflatable balloon on the catheter body. Preferably, the interface surface and associated oscillatory driver are both located entirely within the inflatable balloon, so that the interface surface can be used to transfer ultrasonic energy directly into the inflation medium used to inflate the balloon. Alternatively, the balloon is mounted so that at least one of its forward end and/or distal end is secured to a cylindrical interface surface. In this way, after balloon inflation, the interface surface will directly oscillate one or both ends of the balloon. The catheters of this type will be particularly useful for performing enhanced angioplasty procedures, optionally with stent delivery.
- A third exemplary embodiment of the catheter of the present invention comprises a pair of spaced-apart inflatable balloons on the catheter body. A cylindrical interface surface is disposed between the balloons, with at least one of the distal end of the proximal-most balloon and the proximal end of the distal-most balloon being secured to the interface member. A fluid delivery lumen is provided within the catheter so that a treatment medium can be delivered to the region between the balloons when the balloons are expanded in a blood vessel. Mixing and/or penetration of the treatment medium is enhanced by ultrasonic oscillation of the cylindrical interface surface when the treatment medium is present.
- FIG. 1 illustrates an exemplary catheter incorporating an interface surface having a distal tip and an angioplasty balloon disposed proximally of the interface surface, constructed in accordance with the principles of the present invention.
- FIG. 2 is a detailed view of the distal end of the catheter of FIG. 1, shown in partial section.
- FIG. 3 is a detailed view of the distal end of a first alternative embodiment of the catheter of FIG. 1, wherein the interface surface further extends over a cylindrical portion of the catheter body, shown in partial section.
- FIG. 4 is a detailed view of the distal end of a second alternative embodiment of the catheter of FIG. 1, wherein the angioplasty balloon is attached at its distal end to the interface surface.
- FIG. 5 is a detailed view of the distal end of a third alternative embodiment of the catheter of FIG. 1, wherein the distal end of the angioplasty balloon is attached to the cylindrical portion of the interface surface of the first alternative embodiment of FIG. 2.
- FIGS.6-8 illustrate use of the catheter of FIG. 2 for penetrating a stenotic region within a blood vessel and expanding a vascular stent therein.
- FIG. 9 illustrates the distal end of a fourth alternative embodiment of the catheter of the present invention, wherein a cylindrical interface surface is disposed entirely within an angioplasty balloon.
- FIG. 10 illustrates a fifth alternative embodiment of the catheter of the present invention, wherein the angioplasty balloon is attached at both its proximal and distal ends to a cylindrical interface surface.
- FIG. 11 is a view of the distal end of the catheter of FIG. 9, shown in partial section.
- FIGS. 12 and 13 illustrate use of the catheter of FIG. 9 for expanding a stent within a stenotic region in a blood vessel.
- FIG. 14 illustrates a sixth alternative embodiment of the catheter of the present invention, wherein the catheter includes a pair of axially spaced-apart balloons and wherein the distal end of the proximal-most balloon and the proximal end of the distal-most balloon are each attached to a cylindrical interface surface disposed therebetween.
- The present invention provides apparatus and methods for the treatment of luminal conditions, particularly for the treatment of diseases of the coronary and peripheral vasculature. Specific conditions include coronary and peripheral arterial disease and thrombosis. The apparatus and methods are useful for primary treatment of such diseases, where the purpose is to ablate, dissolve, or otherwise disrupt the clot, plaque, or other stenotic lesions which are responsible for the disease. For example, catheters constructed according to the principles of the present invention can be used to directly engage and transmit vibratory, usually ultrasonic, energy into the stenotic material in order to mechanically disrupt the material to open the associated blood vessel lumen. The catheters of the present invention will also include at least one inflatable balloon in order to perform procedures which combine use of the balloon with the ability to deliver ultrasonic or other vibratory energy.
- Usually, the balloons will be angioplasty balloons useful for engaging and dilatating stenotic regions within a blood vessel. In such cases, the vibratory energy may be used either to enhance initial penetration of the catheter so that the angioplasty balloon can be positioned within the stenotic region (e.g. by softening or disrupting the stenotic material prior to balloon positioning), to soften the stenotic material while the balloon is being expanded with or without a stent, and/or to treat the stenotic region within the blood vessel after the balloon has been used to perform angioplasty, stent placement, or the like. In the latter case, the transfer of ultrasonic energy can reduce the presence of residual clot which can serve as nuclei for subsequent clot formation and restenosis.
- The catheters may also include a pair of spaced-apart balloons, where the balloons define a treatment region therebetween which is useful to enhance the administration of therapeutic agents, where the therapeutic agents are primarily responsible for the disruption of the stenotic material and/or lessening of restenosis subsequent to angioplasty. In such cases, the vibratory energy will be relied on to agitate and promote the penetration of the therapeutic agent into the stenotic material. Suitable therapeutic agents include known thrombolytic and fibrinolytic drugs, such as heparin, tissue plasminogen activator (tPA), urokinase, streptokinase, and the like.
- The catheters of the present invention will comprise a catheter body having a proximal end and distal end. The catheter body will have dimensions and physical characteristics selected for the particular use. For vascular applications, the length of the catheter body will typically be from 50 cm to 200 cm, usually being from 75 cm to 150 cm, and the diameter will be from 1 mm to 5 mm, usually being from 2 mm to 4 mm. The diameter of the catheter body may vary over its length, and different portions of the length may be formed from different materials. In the exemplary embodiment, the catheter body will comprise a single extrusion having at least one lumen therethrough for providing an inflation medium to the balloon. That or another lumen, will usually be capable of receiving a guidewire, and may also be capable of delivering therapeutic agents and/or carrying electrical wires for connection from the proximal end of the catheter body to the distal end. Alternatively, the catheter body may include separate lumens for balloon inflation, delivering therapeutic agent(s), routing electrical wires for connection to the ultrasonic transducer, or other purposes.
- The catheter body may be reinforced over all or a portion of its length. Conventional reinforcement materials include wire braids, wire meshes, wire coils, helical ribbons, and the like.
- When employed with a guidewire for placement within the vasculature, the catheter body may have an “over-the-wire” design or a “rapid exchange” design. In the former case, the guidewire lumen will extend substantially through the entire length of the catheter body. In the latter case, the guidewire lumen will terminate in a proximal guidewire port located relatively near the distal end of the catheter body, usually within 50 cm, more usually within 30 cm, and often within 25 cm or less. Usually, a proximal housing will be secured to the proximal end of the catheter body, where the housing includes a guidewire port, a therapeutic agent infusion port, an electrical connector, and the like.
- A longitudinally vibrating assembly is secured at or near the distal end of the catheter body. The assembly will include at least one interface surface, usually present on an interface member, which is vibrated at a desired frequency, wherein the interface surface is oriented to transmit vibrations to the fluid environment surrounding the distal end of the catheter. The vibrating assembly will usually be attached directly to the distal end of the catheter body but also could be disposed partially or totally within the distal end of the catheter body. Usually, the vibrating assembly will have a relatively short length, typically being below 2 cm, preferably being below 1 cm, and typically being in the range from about 0.4 cm to 1.5 cm, more usually in the range from about 0.6 cm to 1 cm. The assembly will preferably have a low profile (narrow diameter) to facilitate vascular or other intraluminal introductions, typically having a diameter below 6 mm, usually in the range from 1 mm to 5 mm, more usually in the range from 2 mm to 4 mm.
- In a first exemplary embodiment of the present invention, the interface surface will be forwardly disposed so that the surface may engage intraluminal obstructions as the catheter is advanced through the body lumen, such as a blood vessel. In a second exemplary embodiment, the interface member may also or alternatively include an interface surface where at least a portion of the surface is disposed circumferentially about the catheter body. The circumferential portion will usually be a cylinder, and the interface member and surface will oscillate axially (i.e., back and forth generally in the direction of the catheter body). The energy will radiate away from the cylindrical surface of the interface member in a generally uniform pattern, i.e., isotropically (radially outward). Such uniform radiation is particularly advantageous for softening stenotic material and/or for enhancing the penetration of therapeutic agents into a length of an intraluminal wall adjacent a cylindrical interface surface.
- In the exemplary embodiments, the cylindrical interface surface will typically have a length in the range from 4 mm to 30 mm, preferably from 6 mm to 15 mm. The outer diameter of the cylindrical surface will typically be in the range from 2 mm to 5 mm, more usually from 3 mm to 4 mm. The interface member may further include a forwardly disposed lateral surface, typically being formed laterally at the distal end of the cylindrical surface. The lateral surface may itself be flat, convex (in the form of a forwardly disposed dome at the distal end of the cylindrical surface), concave, or irregular. The cylindrical surface and/or the forwardly disposed lateral surface may also have surface irregularities formed therein. For example, a plurality of ridges, protrusions, or the like, may be provided for enhancing the transfer of oscillatory motion into the fluid adjacent the surface.
- An oscillating driver will be provided on the catheter body for oscillating the interface member in a desired manner. Usually, the driver will be separate from the interface member. In some cases, however, it may be possible to provide an oscillatory driver which also defines the interface surface, particularly for radially oscillating drivers as described in copending application Ser. Nos. 08/565,575; 08/566,739; and 08/566,740, the full disclosures of which have previously been incorporated herein by reference. The drivers will usually be ultrasonic transducers, including tubular piezoelectric transducers, piezoelectric stack transducers, magnetostrictive drivers, dectostrictive drivers, or the like. Optionally, the drivers may be incorporated in a resonant drive assembly, typically including a spring element attaching the interface member to the catheter body, where the ultrasonic driver is a longitudinally oscillating driver disposed between the catheter body and the interface member. Longitudinally oscillating drivers will usually be selected to oscillate with an amplitude in the range from 0.05 μm to 50 μm, often from 0.1 μm to 20 μm, preferably from 0.5 μm to 4 μm. The details of such drivers and resonant drive assemblies are set forth in copending application Ser. No. 08/565,575, assigned to the assignee of the present application, the full disclosure of which is incorporated herein by reference.
- The catheters of the present invention will further comprise expansible balloon members disposed proximally and/or distally of the interface surface(s) of the interface member. The expansible members, typically in the form of inflatable non-compliant and/or elastomeric balloons, may be utilized to perform angioplasty or engage a luminal wall to isolate a luminal region to be treated. Materials and designs for incorporating balloons in intravascular and other catheters are well known in the art.
- Referring now to FIG. 1, a
catheter system 10 comprising acatheter 12 constructed in accordance with the principles of the present invention and apower supply 14 is illustrated. Thecatheter 12 includes acatheter body 16 having adistal end 18 and aproximal end 20, and aproximal housing 22 having aballoon inflation port 24 and aguidewire port 26. Usually, thecatheter 12 will have at least a second lumen (not illustrated) for accommodating wires transmitting energy from thepower supply 14 to an ultrasonic transducer, as described hereinafter.Cable 30 extends from theproximal end 20 of thecatheter body 16 and includes aconnector 32 which mates withconnector 32 a oncable 33 from thepower supply 14. Thepower supply 14 will be selected to provide an appropriate current source for driving an ultrasonic transducer, as described in more detail herein below. - The power supply and transducer will be selected so that the ultrasonic driver typically operates in the range from 1 kHz to 300 kHz, preferably from 20 kHz to 80 kHz. For example, the
power supply 14 may comprise a conventional signal generator, such as those commercially available from suppliers such as Hewlett-Packard, Palo Alto, Calif., and Tektronics, Portland, Oreg., and a power amplifier, such as those commercially available from suppliers such as ENI, Rochester, N.Y., and Krohn-Hite Corporation, Avon, Mass. - Referring now to FIGS. 1 and 2, the
catheter 12 includes avibratory assembly 40 at itsdistal end 18. Thevibratory assembly 40 includes adistal tip 42 connected to atail mass 44 by aspring member 46. Conveniently, thedistal tip 42,tail mass 44, and connectingspring 46 may be integrally formed, although such integral construction is not a requirement for the present invention. Anoscillatory drive assembly 50 is disposed between a proximal surface of thedistal tip 42 and a distal surface of thetail mass 44, and may comprise a cylindrical piezoelectric element, such as those described in copending application Ser. Nos. 08/565,575 and 08/566,739, the full disclosures of which have been incorporated herein by reference. Other longitudinal drivers, such as stacked piezoelectric disks and magnetostrictive drivers (as described in copending application Ser. No. 08/566,740, the full disclosure of which has previously been incorporated herein by reference), may also find use. Thevibratory assembly 40 will be able to longitudinally oscillate thedistal tip 42 so that a forwardly disposedlateral surface 52 may be longitudinally oscillated, typically with an amplitude in the range from 0.05 μm to 20 μm. - An
angioplasty balloon 60 is disposed on thecatheter body 12 proximal to thedistal tip 42, typically being spaced-apart from the tip by a length in the range from 0 mm to 30 mm, typically from 2 mm to 10 mm. Theballoon 60 may be inflated through aninflation port 62 which is connected toinflation port 24 on theproximal housing 22. - The distal end of an alternative embodiment of the catheter of FIG. 1 is illustrated in FIG. 3. There, a
vibratory assembly 70 at the distal end 18 (all common elements of the alternative embodiment will be given the same reference numbers) of thecatheter body 12. Thevibratory assembly 70 includes atail mass 44, and aspring 46, each of which are identical to the same elements in the catheter of FIGS. 1 and 2. Instead of thedistal tip 42, the catheter of FIG. 3 includes an interface surface comprising a cylindrical interface surface which extends over a length of the catheter body from 4 mm to 30 mm, preferably from 6 mm to 15 mm. The distal end of the interface surface terminates in alateral surface 52 which may have generally the same geometry as that of the catheter of FIGS. 1 and 2. Theoscillatory driver 50 will generally be the same as that described previously. - The primary difference between the
vibratory assembly 40 andvibratory assembly 70 is in the nature of the interface surface. The interface surface defined bydistal tip 42 and FIGS. 1 and 2 provides only a forwardly disposed,lateral interface 52 surface which is useful for engaging stenotic material directly in front of the catheter. While thevibratory assembly 70 includes an equivalent forwardly disposed interface surface, it further includes a circumferentially disposed cylindrical surface which can impart vibratory energy radially outwardly into fluid surrounding the catheter tip. The nature and advantages of such cylindrical and other laterally disposed interface surfaces are described in more detail in copending application Ser. No. 08/566,739, the full disclosure of which has previously been incorporated herein by reference. - The catheters of FIGS.1-3 each attach the angioplasty balloon directly to the catheter body. Thus, vibration of the interface surfaces of those catheters is not directly coupled to the balloon itself. Referring now to FIGS. 4 and 5, angioplasty balloons may be partly or wholly connected to the interface surfaces which are vibrated by the oscillatory drivers. For example, as illustrated in FIG. 4, a
balloon 80 may be attached at itsproximal end 82 to thecatheter body 12 and at itsdistal end 84 to thedistal tip 42. In this way, the distal end of theballoon 80 may be directly vibrated by thedistal tip 42 in order to impart oscillatory energy to the balloon. The balloon may thus be directly vibrated and enhance the transfer of oscillatory energy into the fluid medium surrounding the catheter. Similarly, aballoon 90 may have itsdistal end 94 attached to thecylindrical interface surface 72 of the catheter of FIG. 3, as illustrated in FIG. 5. - Referring now to FIGS.6-8, the catheter of FIG. 3 may be used to perform angioplasty and optionally deliver a stent ST. Initially, the catheter is delivered over a guidewire GW until the
distal interface surface 52 of the catheter engages the stenotic material S within a blood vessel BV. The oscillatory driver of the catheter is then actuated so that thedistal surface 52 is longitudinally oscillated in order to soften the stenotic material S and enhance penetration of the catheter through the stenotic material. In particular, ultrasonic energy may be radiated forwardly in a pattern indicated bywave front lines 74, as shown in FIG. 6. - After the catheter has penetrated the material in the stenotic region S, the
balloon 60 may be inflated, optionally expanding the stent ST, as illustrated in FIG. 7. After the region has been dilatated, and optionally the stent ST delivered, the catheter may be moved rearwardly so that thecylindrical surface 72 is aligned with the region that has been treated, as illustrated in FIG. 8. The catheter may again be actuated, and thecylindrical surface 72 will transfer ultrasonic wave energy into the medium surrounding the distal end of the catheter, as illustrated by the laterally extendingtransverse wave lines 73 from the surface. The ultrasonic energy will further reduce any residual clot or other stenotic materials which may be present after the dilatation in order to reduce the likelihood of restenosis. - Referring now to FIGS.9-11, further alternative embodiments of the catheter of the present invention will be illustrated. In FIG. 9, a
cylindrical interface surface 100 is disposed completely withininflatable angioplasty balloon 102. Aninflation port 104 is provided on thecatheter body 106, and actuation of the oscillatory driver, as illustrated in FIG. 11, will impart transverse waves into the inflation medium within theballoon 102. In FIG. 10, aballoon 110 is attached at both its distal and proximal ends to acylindrical interface surface 112. In this way, when theinterface surface 112 is actuated, both ends of theballoon 112 will be longitudinally oscillated together with the surface. - Referring now to FIG. 11, a first
tubular transducer 120 and a secondtubular transducer 122 are disposed on the proximal and distal sides of aflange 124 which is located in the middle of atubular holder 126. As illustrated, thetransducers transducers transducer 120 and the distal end oftransducer 122 will remain constant, while the ends of each transducer are displaced axially in a synchronous manner. Aninterface member 130 having thecylindrical interface surface 100 is attached to the respective ends of thefirst transducer 120 and thesecond transducer 122. In this way, the transducers will be driven in a longitudinally oscillating manner at a frequency determined by the characteristics of the transducers and the mass of the interface surface. - Referring now to FIGS. 12 and 13, the catheter of FIGS. 9 and 11 may be used to dilatate and optionally deliver a stent to a region of vascular stenosis S in a blood vessel BV. Initially, the
balloon 102 carrying the stent ST is positioned within the region of stenosis S, and thereafter the balloon is inflated, as illustrated in FIG. 12. In order to further inflate the balloon and implant the stent ST, thetransducers cylindrical surface 102. Such oscillation induces transverse waves within the inflation medium within theballoon 102 as illustrated in FIG. 13. The energy will be further transferred into the blood vessel wall, softening the stenotic material and enhancing expansion of theballoon 102 and stent ST. - Referring now to FIG. 14, a
catheter 150 having aproximal balloon 152 and adistal balloon 154 is illustrated. The balloons are axially spaced-apart, and acylindrical interface surface 156 is disposed therebetween. Theinterface surface 156 may be constructed identically to the transducer assembly of FIG. 11, except that afluid transfer port 158 will be provided in order to deliver a treatment medium to the volume between the spaced-apartballoons balloons delivery port 158. After the treatment medium is delivered to the treatment region, the cylindrical interface surface will be longitudinally oscillated in order to transfer transverse waves into the medium. The distal end of theproximal balloon 152 and proximal end of thedistal balloon 154 are secured to opposite ends of thecylindrical interface surface 156. In this way, the inwardly disposed surfaces of each balloon are oscillated together with theinterface surface 156. Thus, the balloons themselves can further act to impart vibratory energy into the treatment medium contained within the treatment region R. - Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
Claims (1)
1. A method for delivering a stent to a blood vessel, said method comprising:
positioning a catheter carrying a stent within the blood vessel;
inflating a balloon on the catheter within the blood vessel to implant the stent; and
transversely oscillating a transducer disposed within the balloon to deliver oscillatory waves into the blood vessel wall in the region of the stent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/179,669 US20020177889A1 (en) | 1996-09-05 | 2002-06-24 | Ballon catheters having ultraonically driven interface surfaces and methods for their use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/708,589 US5846218A (en) | 1996-09-05 | 1996-09-05 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US09/205,061 US6287272B1 (en) | 1996-09-05 | 1998-12-04 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US09/808,725 US6464660B2 (en) | 1996-09-05 | 2001-03-14 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US10/179,669 US20020177889A1 (en) | 1996-09-05 | 2002-06-24 | Ballon catheters having ultraonically driven interface surfaces and methods for their use |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/808,725 Continuation US6464660B2 (en) | 1996-09-05 | 2001-03-14 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020177889A1 true US20020177889A1 (en) | 2002-11-28 |
Family
ID=24846413
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/708,589 Expired - Fee Related US5846218A (en) | 1996-09-05 | 1996-09-05 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US09/205,061 Expired - Fee Related US6287272B1 (en) | 1996-09-05 | 1998-12-04 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US10/179,669 Abandoned US20020177889A1 (en) | 1996-09-05 | 2002-06-24 | Ballon catheters having ultraonically driven interface surfaces and methods for their use |
US10/210,426 Abandoned US20020188243A1 (en) | 1996-09-05 | 2002-07-31 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/708,589 Expired - Fee Related US5846218A (en) | 1996-09-05 | 1996-09-05 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US09/205,061 Expired - Fee Related US6287272B1 (en) | 1996-09-05 | 1998-12-04 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/210,426 Abandoned US20020188243A1 (en) | 1996-09-05 | 2002-07-31 | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
Country Status (7)
Country | Link |
---|---|
US (4) | US5846218A (en) |
EP (1) | EP1009298A1 (en) |
JP (1) | JP2001500036A (en) |
AU (1) | AU4250897A (en) |
BR (1) | BR9712006A (en) |
CA (1) | CA2260842A1 (en) |
WO (1) | WO1998009571A1 (en) |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060058708A1 (en) * | 2003-12-24 | 2006-03-16 | Gill Heart | Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue |
US20070078505A1 (en) * | 2005-04-05 | 2007-04-05 | Dimitrov Nicolay G | Two-balloon catheter device for coronary angioplasty and its use |
WO2008138997A1 (en) * | 2007-05-16 | 2008-11-20 | Rhinomed Ab | Vibration device |
US20090312768A1 (en) * | 2008-06-13 | 2009-12-17 | Aspen Medtech, Inc. | Shockwave balloon catheter system |
US20090312827A1 (en) * | 2005-12-23 | 2009-12-17 | C.R. Bard Inc. | Balloon catheter with centralized vent hole |
US20100114065A1 (en) * | 2008-11-04 | 2010-05-06 | Daniel Hawkins | Drug delivery shockwave balloon catheter system |
US20100114020A1 (en) * | 2008-11-05 | 2010-05-06 | Daniel Hawkins | Shockwave valvuloplasty catheter system |
US20110034832A1 (en) * | 2009-07-08 | 2011-02-10 | Iulian Cioanta | Usage of Extracorporeal and Intracorporeal Pressure Shock Waves in Medicine |
WO2012106259A2 (en) * | 2011-02-04 | 2012-08-09 | Daniel Hawkins | High pressure balloon shockwave catheter and method |
US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US20140128963A1 (en) * | 2012-11-02 | 2014-05-08 | Medtronic, Inc. | Transcatheter Valve Prosthesis Delivery System With Recapturing Feature and Method |
US8728091B2 (en) | 2012-09-13 | 2014-05-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US8747416B2 (en) | 2012-08-06 | 2014-06-10 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US9011463B2 (en) | 2012-06-27 | 2015-04-21 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US9072534B2 (en) | 2008-06-13 | 2015-07-07 | Shockwave Medical, Inc. | Non-cavitation shockwave balloon catheter system |
US9138249B2 (en) | 2012-08-17 | 2015-09-22 | Shockwave Medical, Inc. | Shock wave catheter system with arc preconditioning |
US9198618B2 (en) | 2011-12-16 | 2015-12-01 | Chordate Medical Ab | Pressure sensing system and method |
US9220521B2 (en) | 2012-08-06 | 2015-12-29 | Shockwave Medical, Inc. | Shockwave catheter |
US9474684B2 (en) | 2012-03-20 | 2016-10-25 | Chordate Medical Ab | Electroactive vibration method |
US9486381B2 (en) | 2011-12-16 | 2016-11-08 | Chordate Medical Ab | ALS treatment |
US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9579114B2 (en) | 2008-05-07 | 2017-02-28 | Northgate Technologies Inc. | Radially-firing electrohydraulic lithotripsy probe |
US9579247B2 (en) | 2011-12-16 | 2017-02-28 | Chordate Medical Ab | Treatment of headache disorders |
US9730715B2 (en) | 2014-05-08 | 2017-08-15 | Shockwave Medical, Inc. | Shock wave guide wire |
US9782320B2 (en) | 2011-12-16 | 2017-10-10 | Chordate Medical Ab | Double stimulation |
US9872814B2 (en) | 2012-03-20 | 2018-01-23 | Chordate Medical Ag | Vibration pattern for vibration stimulation |
US9895279B2 (en) | 2011-12-16 | 2018-02-20 | Chordate Medical Ab | Stimulation of hypothalamus |
US10226265B2 (en) | 2016-04-25 | 2019-03-12 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
US10441300B2 (en) | 2017-04-19 | 2019-10-15 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
US10555744B2 (en) | 2015-11-18 | 2020-02-11 | Shockware Medical, Inc. | Shock wave electrodes |
US10603058B2 (en) | 2013-03-11 | 2020-03-31 | Northgate Technologies, Inc. | Unfocused electrohydraulic lithotripter |
US10646240B2 (en) | 2016-10-06 | 2020-05-12 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
US10702293B2 (en) | 2008-06-13 | 2020-07-07 | Shockwave Medical, Inc. | Two-stage method for treating calcified lesions within the wall of a blood vessel |
US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
US11020135B1 (en) | 2017-04-25 | 2021-06-01 | Shockwave Medical, Inc. | Shock wave device for treating vascular plaques |
US11478261B2 (en) | 2019-09-24 | 2022-10-25 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US11596423B2 (en) | 2018-06-21 | 2023-03-07 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
US11992232B2 (en) | 2020-10-27 | 2024-05-28 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US12023098B2 (en) | 2021-10-05 | 2024-07-02 | Shockwave Medical, Inc. | Lesion crossing shock wave catheter |
US12035932B1 (en) | 2023-04-21 | 2024-07-16 | Shockwave Medical, Inc. | Intravascular lithotripsy catheter with slotted emitter bands |
US12048445B2 (en) | 2022-12-20 | 2024-07-30 | Northgate Technologies, Inc. | Unfocused electrohydraulic lithotripter |
Families Citing this family (154)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
US6176842B1 (en) * | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US6464660B2 (en) * | 1996-09-05 | 2002-10-15 | Pharmasonics, Inc. | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6913763B2 (en) * | 1996-11-19 | 2005-07-05 | Intrabrain International Nv | Method and device for enhanced delivery of a biologically active agent through the spinal spaces into the central nervous system of a mammal |
US6723063B1 (en) | 1998-06-29 | 2004-04-20 | Ekos Corporation | Sheath for use with an ultrasound element |
US6582392B1 (en) | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6676626B1 (en) | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
US6652515B1 (en) | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6514249B1 (en) | 1997-07-08 | 2003-02-04 | Atrionix, Inc. | Positioning system and method for orienting an ablation element within a pulmonary vein ostium |
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
US8709007B2 (en) | 1997-10-15 | 2014-04-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for ablating cardiac tissue |
US6794369B2 (en) * | 1997-12-31 | 2004-09-21 | Pharmasonics | Methods, systems, and kits for intravascular nucleic acid delivery |
WO1999033391A2 (en) * | 1997-12-31 | 1999-07-08 | Pharmasonics, Inc. | Methods and systems for the inhibition of vascular hyperplasia |
AU2023199A (en) * | 1997-12-31 | 1999-07-19 | Pharmasonics, Inc. | Methods, systems, and kits for intravascular nucleic acid delivery |
US6148222A (en) * | 1998-07-10 | 2000-11-14 | Cardiocommand, Inc. | Esophageal catheters and method of use |
US6135976A (en) * | 1998-09-25 | 2000-10-24 | Ekos Corporation | Method, device and kit for performing gene therapy |
US6607502B1 (en) | 1998-11-25 | 2003-08-19 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US6317615B1 (en) | 1999-04-19 | 2001-11-13 | Cardiac Pacemakers, Inc. | Method and system for reducing arterial restenosis in the presence of an intravascular stent |
AU770417B2 (en) | 1999-05-11 | 2004-02-19 | Atrionix, Inc. | Balloon anchor wire |
US6758830B1 (en) | 1999-05-11 | 2004-07-06 | Atrionix, Inc. | Catheter positioning system |
US6398792B1 (en) * | 1999-06-21 | 2002-06-04 | O'connor Lawrence | Angioplasty catheter with transducer using balloon for focusing of ultrasonic energy and method for use |
AU775394B2 (en) * | 1999-07-19 | 2004-07-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US6551337B1 (en) | 1999-10-05 | 2003-04-22 | Omnisonics Medical Technologies, Inc. | Ultrasonic medical device operating in a transverse mode |
US6695782B2 (en) | 1999-10-05 | 2004-02-24 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device with rapid attachment and detachment means |
US20040097996A1 (en) * | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
US6733451B2 (en) | 1999-10-05 | 2004-05-11 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic probe used with a pharmacological agent |
US6660013B2 (en) | 1999-10-05 | 2003-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus for removing plaque from blood vessels using ultrasonic energy |
US6652547B2 (en) * | 1999-10-05 | 2003-11-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using ultrasonic medical device operating in a transverse mode |
US20030236539A1 (en) * | 1999-10-05 | 2003-12-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method for using an ultrasonic probe to clear a vascular access device |
US6508781B1 (en) | 1999-12-30 | 2003-01-21 | Advanced Cardiovascular Systems, Inc. | Ultrasonic ablation catheter transmission wire connector assembly |
US6461383B1 (en) * | 1999-12-30 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Ultrasonic catheter vascular stent system and method |
US7166098B1 (en) | 1999-12-30 | 2007-01-23 | Advanced Cardiovascular Systems, Inc. | Medical assembly with transducer for local delivery of a therapeutic substance and method of using same |
US6589253B1 (en) | 1999-12-30 | 2003-07-08 | Advanced Cardiovascular Systems, Inc. | Ultrasonic angioplasty transmission wire |
US6450975B1 (en) | 1999-12-30 | 2002-09-17 | Advanced Cardiovascular Systems, Inc. | Ultrasonic transmission guide wire |
US6494891B1 (en) | 1999-12-30 | 2002-12-17 | Advanced Cardiovascular Systems, Inc. | Ultrasonic angioplasty transmission member |
US7184827B1 (en) | 2000-01-24 | 2007-02-27 | Stuart D. Edwards | Shrinkage of dilatations in the body |
AU6321301A (en) * | 2000-05-16 | 2001-11-26 | Atrionix Inc | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
ATE290827T1 (en) | 2000-06-13 | 2005-04-15 | Atrionix Inc | SURGICAL ABLATION PROBE FOR FORMING AN ANNUAL LESION |
US20040158317A1 (en) * | 2000-07-18 | 2004-08-12 | Pharmasonics, Inc. | Coated stent with ultrasound therapy |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US6416540B1 (en) | 2000-11-01 | 2002-07-09 | Sandip V. Mathur | Magnetically actuated cleanable stent and method |
US6740040B1 (en) * | 2001-01-30 | 2004-05-25 | Advanced Cardiovascular Systems, Inc. | Ultrasound energy driven intraventricular catheter to treat ischemia |
US7493162B2 (en) | 2001-06-15 | 2009-02-17 | Cardiac Pacemakers, Inc. | Pulmonary vein stent for treating atrial fibrillation |
US6554846B2 (en) | 2001-09-28 | 2003-04-29 | Scimed Life Systems, Inc. | Sonic burr |
US8974446B2 (en) * | 2001-10-11 | 2015-03-10 | St. Jude Medical, Inc. | Ultrasound ablation apparatus with discrete staggered ablation zones |
US7285116B2 (en) * | 2004-05-15 | 2007-10-23 | Irvine Biomedical Inc. | Non-contact tissue ablation device and methods thereof |
EP1434526A1 (en) * | 2001-10-12 | 2004-07-07 | Boston Scientific Limited | Catheter with piezo elements for lesion diagnostics |
ATE520362T1 (en) | 2001-12-03 | 2011-09-15 | Ekos Corp | CATHETER WITH MULTIPLE ULTRASONIC EMITTING PARTS |
US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
US7211055B2 (en) * | 2002-01-15 | 2007-05-01 | The Regents Of The University Of California | System and method providing directional ultrasound therapy to skeletal joints |
US7819826B2 (en) * | 2002-01-23 | 2010-10-26 | The Regents Of The University Of California | Implantable thermal treatment method and apparatus |
AU2003215119B2 (en) * | 2002-02-11 | 2008-11-20 | Gold-T Tech, Inc. | Method for preventing thrombus formation |
US20070293855A1 (en) * | 2002-02-15 | 2007-12-20 | Sliwa John W Jr | Methods and devices for ablation |
US7236821B2 (en) * | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
US7153315B2 (en) * | 2002-06-11 | 2006-12-26 | Boston Scientific Scimed, Inc. | Catheter balloon with ultrasonic microscalpel blades |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US6942677B2 (en) * | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US7220233B2 (en) | 2003-04-08 | 2007-05-22 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US7604608B2 (en) * | 2003-01-14 | 2009-10-20 | Flowcardia, Inc. | Ultrasound catheter and methods for making and using same |
US8613744B2 (en) | 2002-09-30 | 2013-12-24 | Relievant Medsystems, Inc. | Systems and methods for navigating an instrument through bone |
US8361067B2 (en) | 2002-09-30 | 2013-01-29 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
US7258690B2 (en) | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
US8808284B2 (en) | 2008-09-26 | 2014-08-19 | Relievant Medsystems, Inc. | Systems for navigating an instrument through bone |
US6907884B2 (en) | 2002-09-30 | 2005-06-21 | Depay Acromed, Inc. | Method of straddling an intraosseous nerve |
US6921371B2 (en) | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
US7771372B2 (en) | 2003-01-03 | 2010-08-10 | Ekos Corporation | Ultrasonic catheter with axial energy field |
US20040230116A1 (en) * | 2003-05-12 | 2004-11-18 | Pharmasonics, Inc. | Method and apparatus for detection of ultrasound transducer failure in catheter systems |
US20050059993A1 (en) * | 2003-09-17 | 2005-03-17 | Kamal Ramzipoor | Embolectomy device |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
US9107590B2 (en) | 2004-01-29 | 2015-08-18 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
US7794414B2 (en) | 2004-02-09 | 2010-09-14 | Emigrant Bank, N.A. | Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes |
EP1786502A2 (en) * | 2004-07-15 | 2007-05-23 | Incumed | Device and method for treating a blood vessel |
US7567841B2 (en) | 2004-08-20 | 2009-07-28 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering combined electrical and drug therapies |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
JP5220412B2 (en) * | 2004-09-13 | 2013-06-26 | バイオセンス・ウエブスター・インコーポレーテツド | Ablation device with phased array ultrasonic transducer |
US8221343B2 (en) | 2005-01-20 | 2012-07-17 | Flowcardia, Inc. | Vibrational catheter devices and methods for making same |
US7499748B2 (en) | 2005-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Transvascular neural stimulation device |
US7617003B2 (en) | 2005-05-16 | 2009-11-10 | Cardiac Pacemakers, Inc. | System for selective activation of a nerve trunk using a transvascular reshaping lead |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US7616990B2 (en) | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
AR054423A3 (en) * | 2006-01-11 | 2007-06-27 | Spinlock S R L | AN APPLIANCE AND METHOD FOR MEASURING THE FLOW AND CUTTING OF OIL AND WATER FROM OIL PRODUCTION IN TIME AND REAL FLOWS |
US9282984B2 (en) | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
US20070265560A1 (en) | 2006-04-24 | 2007-11-15 | Ekos Corporation | Ultrasound Therapy System |
GB0700560D0 (en) * | 2007-01-11 | 2007-02-21 | Emcision Ltd | Device and method for the treatment of diseased tissue such as tumours |
WO2008031033A2 (en) * | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US8192363B2 (en) | 2006-10-27 | 2012-06-05 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
WO2008086372A1 (en) | 2007-01-08 | 2008-07-17 | Ekos Corporation | Power parameters for ultrasonic catheter |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
WO2008125145A1 (en) * | 2007-04-13 | 2008-10-23 | Synergio Ag | A tissue penetration device and method |
US9314298B2 (en) | 2007-04-17 | 2016-04-19 | St. Jude Medical, Atrial Fibrillation Divisions, Inc. | Vacuum-stabilized ablation system |
JP2010527678A (en) * | 2007-05-23 | 2010-08-19 | オスシロン リミテッド | Apparatus and method for guided penetration of chronic total occlusion |
WO2009002881A1 (en) | 2007-06-22 | 2008-12-31 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
JP2010540160A (en) | 2007-10-05 | 2010-12-24 | マッケ カーディオバスキュラー,エルエルシー | Apparatus and method for minimally invasive surgical procedures |
US8939991B2 (en) | 2008-06-08 | 2015-01-27 | Hotspur Technologies, Inc. | Apparatus and methods for removing obstructive material from body lumens |
US8945160B2 (en) | 2008-07-03 | 2015-02-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US9101382B2 (en) * | 2009-02-18 | 2015-08-11 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
EP2326264B1 (en) * | 2008-07-27 | 2017-11-15 | Pi-R-Squared Ltd. | Fracturing calcifications in heart valves |
US8257378B1 (en) * | 2008-07-28 | 2012-09-04 | O'connor Lawrence R | Ultrasonic guide wire for disintegration and dispersion of arterial occlusions of thrombi and plaque |
US9005274B2 (en) * | 2008-08-04 | 2015-04-14 | Stentys Sas | Method for treating a body lumen |
EP3406210A1 (en) | 2008-09-26 | 2018-11-28 | Relievant Medsystems, Inc. | Systems and for navigating an instrument through bone |
US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
US20100168741A1 (en) * | 2008-12-29 | 2010-07-01 | Hideo Sanai | Surgical operation apparatus |
US20120109057A1 (en) | 2009-02-18 | 2012-05-03 | Hotspur Technologies, Inc. | Apparatus and methods for treating obstructions within body lumens |
US8226566B2 (en) | 2009-06-12 | 2012-07-24 | Flowcardia, Inc. | Device and method for vascular re-entry |
EP2448636B1 (en) | 2009-07-03 | 2014-06-18 | Ekos Corporation | Power parameters for ultrasonic catheter |
US20110082534A1 (en) * | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
US20120215099A1 (en) * | 2009-10-06 | 2012-08-23 | Wallace Michael P | Methods and Apparatus for Endovascular Ultrasound Delivery |
US20110105960A1 (en) * | 2009-10-06 | 2011-05-05 | Wallace Michael P | Ultrasound-enhanced Stenosis therapy |
US9375223B2 (en) * | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110082396A1 (en) * | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
US11039845B2 (en) | 2009-10-06 | 2021-06-22 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110082414A1 (en) * | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
US8740835B2 (en) | 2010-02-17 | 2014-06-03 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
EP2608730B1 (en) | 2010-08-27 | 2019-07-24 | Ekos Corporation | Apparatus for treatment of intracranial hemorrhages |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
JP5731965B2 (en) * | 2011-12-27 | 2015-06-10 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US10390877B2 (en) | 2011-12-30 | 2019-08-27 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
WO2013109269A1 (en) | 2012-01-18 | 2013-07-25 | Bard Peripheral Vascular, Inc. | Vascular re-entry device |
RU2640564C2 (en) | 2012-08-02 | 2018-01-09 | Бард Периферэл Васкьюлар | Ultrasonic catheter system |
AU2013299562C1 (en) | 2012-08-08 | 2017-11-30 | Shockwave Medical, Inc. | Shockwave valvuloplasty with multiple balloons |
US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
WO2014071161A1 (en) | 2012-11-05 | 2014-05-08 | Relievant Medsystems, Inc. | System and methods for creating curved paths through bone and modulating nerves within the bone |
CA2895790A1 (en) * | 2012-12-21 | 2014-06-26 | Paul Hoseit | Imaging catheter for imaging from within balloon |
EP2938386B1 (en) * | 2012-12-28 | 2019-01-30 | Bard Peripheral Vascular, Inc. | Drug delivery via mechanical vibration balloon |
JP6479753B2 (en) | 2013-03-14 | 2019-03-06 | エコス コーポレーション | Method and apparatus for delivering a drug to a target location |
US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
WO2015074036A2 (en) * | 2013-11-18 | 2015-05-21 | Jeremy Stigall | Methods and devices for thrombus dispersal |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
EP3307388B1 (en) | 2015-06-10 | 2022-06-22 | Ekos Corporation | Ultrasound catheter |
EP3534808A4 (en) * | 2016-11-04 | 2020-06-10 | Les Solutions Médicales Soundbite Inc. | Device for delivering mechanical waves through a balloon catheter |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
US10470748B2 (en) | 2017-04-03 | 2019-11-12 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with expandable portion |
EA033442B1 (en) * | 2017-07-20 | 2019-10-31 | Oralbaj Darmenov | Device for selective ultrasonic dissection of atherosclerotic plaques and method of restoring arterial vessels permeability |
WO2019200201A1 (en) | 2018-04-12 | 2019-10-17 | The Regents Of The University Of Michigan | System for effecting and controlling oscillatory pressure within balloon catheters for fatigue fracture of calculi |
US20210030432A1 (en) * | 2019-07-30 | 2021-02-04 | National Tsing Hua University | Vortex catheter thrombolytic system and thrombolytic method thereof |
EP4027912A4 (en) | 2019-09-12 | 2023-08-16 | Relievant Medsystems, Inc. | Systems and methods for tissue modulation |
CN112472968A (en) * | 2020-12-03 | 2021-03-12 | 广东博迈医疗器械有限公司 | Ultrasonic nicking catheter |
US12039731B2 (en) | 2020-12-22 | 2024-07-16 | Relievant Medsystems, Inc. | Prediction of candidates for spinal neuromodulation |
WO2024112570A1 (en) * | 2022-11-22 | 2024-05-30 | Provisio Medical, Inc. | Multifrequency ultrasound measuring systems and methods |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6527759B1 (en) * | 1995-03-05 | 2003-03-04 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3433226A (en) * | 1965-07-21 | 1969-03-18 | Aeroprojects Inc | Vibratory catheterization apparatus and method of using |
US3565062A (en) * | 1968-06-13 | 1971-02-23 | Ultrasonic Systems | Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like |
CA1237482A (en) * | 1984-03-09 | 1988-05-31 | Frank B. Stiles | Catheter for effecting removal of obstructions from a biological duct |
EP0189329A3 (en) * | 1985-01-25 | 1987-06-03 | Robert E. Fischell | A tunneling catheter system for transluminal arterial angioplasty |
US4698058A (en) * | 1985-10-15 | 1987-10-06 | Albert R. Greenfeld | Ultrasonic self-cleaning catheter system for indwelling drains and medication supply |
US4948587A (en) * | 1986-07-08 | 1990-08-14 | Massachusetts Institute Of Technology | Ultrasound enhancement of transbuccal drug delivery |
US4808153A (en) * | 1986-11-17 | 1989-02-28 | Ultramed Corporation | Device for removing plaque from arteries |
US4870953A (en) * | 1987-11-13 | 1989-10-03 | Donmicheal T Anthony | Intravascular ultrasonic catheter/probe and method for treating intravascular blockage |
US5053044A (en) * | 1988-01-11 | 1991-10-01 | Devices For Vascular Intervention, Inc. | Catheter and method for making intravascular incisions |
US5163421A (en) * | 1988-01-22 | 1992-11-17 | Angiosonics, Inc. | In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging |
US4920954A (en) * | 1988-08-05 | 1990-05-01 | Sonic Needle Corporation | Ultrasonic device for applying cavitation forces |
US5458631A (en) * | 1989-01-06 | 1995-10-17 | Xavier; Ravi | Implantable catheter with electrical pulse nerve stimulators and drug delivery system |
US4936281A (en) * | 1989-04-13 | 1990-06-26 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
JPH0363041A (en) * | 1989-07-31 | 1991-03-19 | Olympus Optical Co Ltd | Ultrasonic therapeutic apparatus |
US5085662A (en) * | 1989-11-13 | 1992-02-04 | Scimed Life Systems, Inc. | Atherectomy catheter and related components |
US5344395A (en) * | 1989-11-13 | 1994-09-06 | Scimed Life Systems, Inc. | Apparatus for intravascular cavitation or delivery of low frequency mechanical energy |
US5117831A (en) * | 1990-03-28 | 1992-06-02 | Cardiovascular Imaging Systems, Inc. | Vascular catheter having tandem imaging and dilatation components |
US5181920A (en) * | 1990-06-08 | 1993-01-26 | Devices For Vascular Intervention, Inc. | Atherectomy device with angioplasty balloon and method |
CA2081896A1 (en) * | 1990-06-15 | 1991-12-16 | James E. Shapland | Drug delivery apparatus and method |
US5279546A (en) * | 1990-06-27 | 1994-01-18 | Lake Region Manufacturing Company, Inc. | Thrombolysis catheter system |
US5197946A (en) * | 1990-06-27 | 1993-03-30 | Shunro Tachibana | Injection instrument with ultrasonic oscillating element |
US5269291A (en) * | 1990-12-10 | 1993-12-14 | Coraje, Inc. | Miniature ultrasonic transducer for plaque ablation |
US5324255A (en) * | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
US5267954A (en) * | 1991-01-11 | 1993-12-07 | Baxter International Inc. | Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels |
US5447509A (en) * | 1991-01-11 | 1995-09-05 | Baxter International Inc. | Ultrasound catheter system having modulated output with feedback control |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
ATE146073T1 (en) * | 1991-03-22 | 1996-12-15 | Katsuro Tachibana | AMPLIFIER FOR ULTRASONIC THERAPY OF DISEASES AND LIQUID MEDICINAL COMPOSITIONS CONTAINING SAME |
US5458568A (en) * | 1991-05-24 | 1995-10-17 | Cortrak Medical, Inc. | Porous balloon for selective dilatation and drug delivery |
GB2258364A (en) * | 1991-07-30 | 1993-02-03 | Intravascular Res Ltd | Ultrasonic tranducer |
CA2122834C (en) * | 1991-11-04 | 1999-10-05 | Henry Nita | Ultrasonic ablation device adapted for guidewire passage |
US5269297A (en) * | 1992-02-27 | 1993-12-14 | Angiosonics Inc. | Ultrasonic transmission apparatus |
US5380273A (en) * | 1992-05-19 | 1995-01-10 | Dubrul; Will R. | Vibrating catheter |
US5713848A (en) * | 1993-05-19 | 1998-02-03 | Dubrul; Will R. | Vibrating catheter |
US5672153A (en) * | 1992-08-12 | 1997-09-30 | Vidamed, Inc. | Medical probe device and method |
EP0611311A1 (en) * | 1992-08-28 | 1994-08-24 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus and method |
US5318014A (en) * | 1992-09-14 | 1994-06-07 | Coraje, Inc. | Ultrasonic ablation/dissolution transducer |
US5362309A (en) * | 1992-09-14 | 1994-11-08 | Coraje, Inc. | Apparatus and method for enhanced intravascular phonophoresis including dissolution of intravascular blockage and concomitant inhibition of restenosis |
EP0623360B1 (en) * | 1993-02-05 | 1999-03-31 | The Joe W. And Dorothy Dorsett Brown Foundation | Ultrasonic angioplasty balloon catheter |
US5267985A (en) * | 1993-02-11 | 1993-12-07 | Trancell, Inc. | Drug delivery by multiple frequency phonophoresis |
US5462523A (en) * | 1993-05-18 | 1995-10-31 | Target Therapeutics, Inc. | Drug delivery system |
US5465725A (en) * | 1993-06-15 | 1995-11-14 | Hewlett Packard Company | Ultrasonic probe |
US5413107A (en) * | 1994-02-16 | 1995-05-09 | Tetrad Corporation | Ultrasonic probe having articulated structure and rotatable transducer head |
AU1889595A (en) * | 1994-03-07 | 1995-09-25 | Medisonic A/S | Apparatus for non-invasive tissue destruction by means of ultrasound |
US5728123A (en) * | 1995-04-26 | 1998-03-17 | Lemelson; Jerome H. | Balloon actuated catheter |
-
1996
- 1996-09-05 US US08/708,589 patent/US5846218A/en not_active Expired - Fee Related
-
1997
- 1997-09-05 CA CA002260842A patent/CA2260842A1/en not_active Abandoned
- 1997-09-05 BR BR9712006A patent/BR9712006A/en not_active Application Discontinuation
- 1997-09-05 WO PCT/US1997/015587 patent/WO1998009571A1/en not_active Application Discontinuation
- 1997-09-05 JP JP10512902A patent/JP2001500036A/en active Pending
- 1997-09-05 AU AU42508/97A patent/AU4250897A/en not_active Abandoned
- 1997-09-05 EP EP97940817A patent/EP1009298A1/en not_active Withdrawn
-
1998
- 1998-12-04 US US09/205,061 patent/US6287272B1/en not_active Expired - Fee Related
-
2002
- 2002-06-24 US US10/179,669 patent/US20020177889A1/en not_active Abandoned
- 2002-07-31 US US10/210,426 patent/US20020188243A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6527759B1 (en) * | 1995-03-05 | 2003-03-04 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
Cited By (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060058708A1 (en) * | 2003-12-24 | 2006-03-16 | Gill Heart | Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue |
US20070078505A1 (en) * | 2005-04-05 | 2007-04-05 | Dimitrov Nicolay G | Two-balloon catheter device for coronary angioplasty and its use |
US20090312827A1 (en) * | 2005-12-23 | 2009-12-17 | C.R. Bard Inc. | Balloon catheter with centralized vent hole |
WO2008138997A1 (en) * | 2007-05-16 | 2008-11-20 | Rhinomed Ab | Vibration device |
US9849062B2 (en) | 2007-05-16 | 2017-12-26 | Chordate Medical Ab | Vibration device |
US10772792B2 (en) | 2007-05-16 | 2020-09-15 | Chordate Medical Ab | Vibration device |
US20100274164A1 (en) * | 2007-05-16 | 2010-10-28 | Rhinomed Ab | Vibration device |
US11559318B2 (en) | 2008-05-07 | 2023-01-24 | Northgate Technologies Inc. | Radially-firing electrohydraulic lithotripsy probe |
US9579114B2 (en) | 2008-05-07 | 2017-02-28 | Northgate Technologies Inc. | Radially-firing electrohydraulic lithotripsy probe |
US20110166570A1 (en) * | 2008-06-13 | 2011-07-07 | Daniel Hawkins | Shockwave balloon catheter system |
US9011462B2 (en) | 2008-06-13 | 2015-04-21 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
US10959743B2 (en) | 2008-06-13 | 2021-03-30 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
US11771449B2 (en) | 2008-06-13 | 2023-10-03 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
US10702293B2 (en) | 2008-06-13 | 2020-07-07 | Shockwave Medical, Inc. | Two-stage method for treating calcified lesions within the wall of a blood vessel |
US10039561B2 (en) | 2008-06-13 | 2018-08-07 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
WO2009152352A3 (en) * | 2008-06-13 | 2010-04-29 | Aspen Medtech, Inc. | Shockwave balloon catheter system |
US20090312768A1 (en) * | 2008-06-13 | 2009-12-17 | Aspen Medtech, Inc. | Shockwave balloon catheter system |
US9072534B2 (en) | 2008-06-13 | 2015-07-07 | Shockwave Medical, Inc. | Non-cavitation shockwave balloon catheter system |
US8956374B2 (en) | 2008-06-13 | 2015-02-17 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
US8956371B2 (en) | 2008-06-13 | 2015-02-17 | Shockwave Medical, Inc. | Shockwave balloon catheter system |
US20100114065A1 (en) * | 2008-11-04 | 2010-05-06 | Daniel Hawkins | Drug delivery shockwave balloon catheter system |
US9180280B2 (en) | 2008-11-04 | 2015-11-10 | Shockwave Medical, Inc. | Drug delivery shockwave balloon catheter system |
US10149690B2 (en) | 2008-11-05 | 2018-12-11 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
US9421025B2 (en) | 2008-11-05 | 2016-08-23 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
US11000299B2 (en) | 2008-11-05 | 2021-05-11 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
US9044618B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
US9044619B2 (en) | 2008-11-05 | 2015-06-02 | Shockwave Medical, Inc. | Shockwave valvuloplasty catheter system |
US20100114020A1 (en) * | 2008-11-05 | 2010-05-06 | Daniel Hawkins | Shockwave valvuloplasty catheter system |
US20110034832A1 (en) * | 2009-07-08 | 2011-02-10 | Iulian Cioanta | Usage of Extracorporeal and Intracorporeal Pressure Shock Waves in Medicine |
US12004759B2 (en) | 2009-07-08 | 2024-06-11 | Sanuwave, Inc. | Catheter with shock wave electrodes aligned on longitudinal axis |
US11666348B2 (en) | 2009-07-08 | 2023-06-06 | Sanuwave, Inc. | Intracorporeal expandable shock wave reflector |
US10639051B2 (en) | 2009-07-08 | 2020-05-05 | Sanuwave, Inc. | Occlusion and clot treatment with intracorporeal pressure shock waves |
US11925366B2 (en) | 2009-07-08 | 2024-03-12 | Sanuwave, Inc. | Catheter with multiple shock wave generators |
US8556813B2 (en) | 2009-07-08 | 2013-10-15 | Sanuwave, Inc. | Extracorporeal pressure shock wave device |
US10238405B2 (en) | 2009-07-08 | 2019-03-26 | Sanuwave, Inc. | Blood vessel treatment with intracorporeal pressure shock waves |
US10058340B2 (en) | 2009-07-08 | 2018-08-28 | Sanuwave, Inc. | Extracorporeal pressure shock wave devices with multiple reflectors and methods for using these devices |
US12004760B2 (en) | 2009-07-08 | 2024-06-11 | Sanuwave, Inc. | Catheter with shock wave electrodes aligned on longitudinal axis |
WO2012106259A2 (en) * | 2011-02-04 | 2012-08-09 | Daniel Hawkins | High pressure balloon shockwave catheter and method |
WO2012106259A3 (en) * | 2011-02-04 | 2013-01-31 | Daniel Hawkins | High pressure balloon shockwave catheter and method |
US9289224B2 (en) | 2011-11-08 | 2016-03-22 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US10478202B2 (en) | 2011-11-08 | 2019-11-19 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US9814476B2 (en) | 2011-11-08 | 2017-11-14 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US8709075B2 (en) | 2011-11-08 | 2014-04-29 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US8574247B2 (en) | 2011-11-08 | 2013-11-05 | Shockwave Medical, Inc. | Shock wave valvuloplasty device with moveable shock wave generator |
US10758446B2 (en) | 2011-12-16 | 2020-09-01 | Chordate Medical Ab | Treatment of headache disorders |
US9782320B2 (en) | 2011-12-16 | 2017-10-10 | Chordate Medical Ab | Double stimulation |
US9579247B2 (en) | 2011-12-16 | 2017-02-28 | Chordate Medical Ab | Treatment of headache disorders |
US9486381B2 (en) | 2011-12-16 | 2016-11-08 | Chordate Medical Ab | ALS treatment |
US9895279B2 (en) | 2011-12-16 | 2018-02-20 | Chordate Medical Ab | Stimulation of hypothalamus |
US11452666B2 (en) | 2011-12-16 | 2022-09-27 | Chordate Medical Ab | Treatment of headache disorders |
US9451889B2 (en) | 2011-12-16 | 2016-09-27 | Chordate Medical Ab | Pressure sensing system and method |
US12042465B2 (en) | 2011-12-16 | 2024-07-23 | Chordate Medical Ab | Treatment of headache disorders |
US9198618B2 (en) | 2011-12-16 | 2015-12-01 | Chordate Medical Ab | Pressure sensing system and method |
US9872814B2 (en) | 2012-03-20 | 2018-01-23 | Chordate Medical Ag | Vibration pattern for vibration stimulation |
US9474684B2 (en) | 2012-03-20 | 2016-10-25 | Chordate Medical Ab | Electroactive vibration method |
US11696799B2 (en) | 2012-06-27 | 2023-07-11 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US10682178B2 (en) | 2012-06-27 | 2020-06-16 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US9993292B2 (en) | 2012-06-27 | 2018-06-12 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US9011463B2 (en) | 2012-06-27 | 2015-04-21 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US9642673B2 (en) | 2012-06-27 | 2017-05-09 | Shockwave Medical, Inc. | Shock wave balloon catheter with multiple shock wave sources |
US10206698B2 (en) | 2012-08-06 | 2019-02-19 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US11076874B2 (en) | 2012-08-06 | 2021-08-03 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US8747416B2 (en) | 2012-08-06 | 2014-06-10 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US8888788B2 (en) | 2012-08-06 | 2014-11-18 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US9433428B2 (en) | 2012-08-06 | 2016-09-06 | Shockwave Medical, Inc. | Low profile electrodes for an angioplasty shock wave catheter |
US9220521B2 (en) | 2012-08-06 | 2015-12-29 | Shockwave Medical, Inc. | Shockwave catheter |
US9138249B2 (en) | 2012-08-17 | 2015-09-22 | Shockwave Medical, Inc. | Shock wave catheter system with arc preconditioning |
US11432834B2 (en) | 2012-09-13 | 2022-09-06 | Shockwave Medical, Inc. | Shock wave catheter system with energy control |
US8728091B2 (en) | 2012-09-13 | 2014-05-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US11596424B2 (en) | 2012-09-13 | 2023-03-07 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9333000B2 (en) | 2012-09-13 | 2016-05-10 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US10159505B2 (en) | 2012-09-13 | 2018-12-25 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US9005216B2 (en) | 2012-09-13 | 2015-04-14 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US10517621B1 (en) | 2012-09-13 | 2019-12-31 | Shockwave Medical, Inc. | Method of managing energy delivered by a shockwave through dwell time compensation |
US10517620B2 (en) | 2012-09-13 | 2019-12-31 | Shockwave Medical, Inc. | Shock wave catheter system with energy control |
US9522012B2 (en) | 2012-09-13 | 2016-12-20 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US10973538B2 (en) | 2012-09-13 | 2021-04-13 | Shockwave Medical, Inc. | Shockwave catheter system with energy control |
US11826250B2 (en) | 2012-11-02 | 2023-11-28 | Medtronic, Inc. | Transcatheter valve prosthesis delivery system with recapturing feature and method |
US9675456B2 (en) * | 2012-11-02 | 2017-06-13 | Medtronic, Inc. | Transcatheter valve prosthesis delivery system with recapturing feature and method |
US20140128963A1 (en) * | 2012-11-02 | 2014-05-08 | Medtronic, Inc. | Transcatheter Valve Prosthesis Delivery System With Recapturing Feature and Method |
US10743989B2 (en) | 2012-11-02 | 2020-08-18 | Medtronic, Inc. | Transcatheter valve prosthesis delivery system with recapturing feature and method |
US11559319B2 (en) | 2013-03-11 | 2023-01-24 | Northgate Technologies Inc. | Unfocused electrohydraulic lithotripter |
US10603058B2 (en) | 2013-03-11 | 2020-03-31 | Northgate Technologies, Inc. | Unfocused electrohydraulic lithotripter |
US10420569B2 (en) | 2014-05-08 | 2019-09-24 | Shockwave Medical, Inc. | Shock wave guide wire |
US9730715B2 (en) | 2014-05-08 | 2017-08-15 | Shockwave Medical, Inc. | Shock wave guide wire |
US10555744B2 (en) | 2015-11-18 | 2020-02-11 | Shockware Medical, Inc. | Shock wave electrodes |
US11337713B2 (en) | 2015-11-18 | 2022-05-24 | Shockwave Medical, Inc. | Shock wave electrodes |
US10226265B2 (en) | 2016-04-25 | 2019-03-12 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
US11026707B2 (en) | 2016-04-25 | 2021-06-08 | Shockwave Medical, Inc. | Shock wave device with polarity switching |
US11517337B2 (en) | 2016-10-06 | 2022-12-06 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
US10646240B2 (en) | 2016-10-06 | 2020-05-12 | Shockwave Medical, Inc. | Aortic leaflet repair using shock wave applicators |
US10357264B2 (en) | 2016-12-06 | 2019-07-23 | Shockwave Medical, Inc. | Shock wave balloon catheter with insertable electrodes |
US10441300B2 (en) | 2017-04-19 | 2019-10-15 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
US11517338B2 (en) | 2017-04-19 | 2022-12-06 | Shockwave Medical, Inc. | Drug delivery shock wave balloon catheter system |
US11020135B1 (en) | 2017-04-25 | 2021-06-01 | Shockwave Medical, Inc. | Shock wave device for treating vascular plaques |
US11602363B2 (en) | 2017-06-19 | 2023-03-14 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
US11950793B2 (en) | 2017-06-19 | 2024-04-09 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
US10966737B2 (en) | 2017-06-19 | 2021-04-06 | Shockwave Medical, Inc. | Device and method for generating forward directed shock waves |
US10709462B2 (en) | 2017-11-17 | 2020-07-14 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
US11622780B2 (en) | 2017-11-17 | 2023-04-11 | Shockwave Medical, Inc. | Low profile electrodes for a shock wave catheter |
US11596423B2 (en) | 2018-06-21 | 2023-03-07 | Shockwave Medical, Inc. | System for treating occlusions in body lumens |
US11478261B2 (en) | 2019-09-24 | 2022-10-25 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US11992232B2 (en) | 2020-10-27 | 2024-05-28 | Shockwave Medical, Inc. | System for treating thrombus in body lumens |
US12023098B2 (en) | 2021-10-05 | 2024-07-02 | Shockwave Medical, Inc. | Lesion crossing shock wave catheter |
US12048445B2 (en) | 2022-12-20 | 2024-07-30 | Northgate Technologies, Inc. | Unfocused electrohydraulic lithotripter |
US12035932B1 (en) | 2023-04-21 | 2024-07-16 | Shockwave Medical, Inc. | Intravascular lithotripsy catheter with slotted emitter bands |
Also Published As
Publication number | Publication date |
---|---|
US6287272B1 (en) | 2001-09-11 |
AU4250897A (en) | 1998-03-26 |
US5846218A (en) | 1998-12-08 |
WO1998009571A1 (en) | 1998-03-12 |
EP1009298A1 (en) | 2000-06-21 |
BR9712006A (en) | 1999-08-24 |
CA2260842A1 (en) | 1998-03-12 |
US20020188243A1 (en) | 2002-12-12 |
JP2001500036A (en) | 2001-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6464660B2 (en) | Balloon catheters having ultrasonically driven interface surfaces and methods for their use | |
US6287272B1 (en) | Balloon catheters having ultrasonically driven interface surfaces and methods for their use | |
US5735811A (en) | Apparatus and methods for ultrasonically enhanced fluid delivery | |
US5725494A (en) | Apparatus and methods for ultrasonically enhanced intraluminal therapy | |
US5931805A (en) | Catheters comprising bending transducers and methods for their use | |
US5728062A (en) | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers | |
US6221038B1 (en) | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers | |
WO1997019645A9 (en) | Apparatus and methods for ultrasonically enhanced fluid delivery | |
US11134966B2 (en) | Drug delivery via mechanical vibration balloon | |
JP4890674B2 (en) | Sheath used for ultrasonic elements | |
US6228046B1 (en) | Catheters comprising a plurality of oscillators and methods for their use | |
US20050096669A1 (en) | Apparatus and method for an ultrasonic medical device to treat coronary thrombus bearing lesions | |
EP2967609B1 (en) | Assisted cutting balloon | |
US6024718A (en) | Intraluminal directed ultrasound delivery device | |
US20040249401A1 (en) | Apparatus and method for an ultrasonic medical device with a non-compliant balloon | |
US20050119679A1 (en) | Apparatus and method for an ultrasonic medical device to treat chronic total occlusions | |
US20050043629A1 (en) | Apparatus and method for an ultrasonic medical device having a probe with a small proximal end | |
WO2005034793A2 (en) | Apparatus and method for an ultrasonic medical device with a non-compliant balloon | |
US20050256410A1 (en) | Apparatus and method for an ultrasonic probe capable of bending with aid of a balloon | |
CN115634010B (en) | Ultrasonic thrombolysis device and ultrasonic thrombolysis system | |
WO2005115545A1 (en) | Ultrasonic probe capable of bending with aid of a balloon | |
WO2024054648A1 (en) | Systems and methods for an ultrasound catheter | |
CN117379134A (en) | Lithotripter device | |
CN116058919A (en) | Thrombus dissipation catheter and balloon catheter assembly with same | |
WO2006049600A1 (en) | Apparatus and method for an ultrasonic medical device to treat coronary thrombus bearing lesions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |